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ABSTRACT 
 Targeting of key events in viral infection pathways creates opportunities for virus 
disease prevention and therapy. Nanoparticles with well-defined surfaces are promising 
tools for the direct visualization of biological processes and for interrogating virus 
behavior that is usually determined by the synergistic interplay of multiple factors and 
involves various transient signaling steps. Smart nanoparticles mimicking enveloped viral 
particles are thus developed and tested in this work with the aim to de-couple key steps in 
human immune-deficiency virus HIV-1 trans-infection with an engineerable viral model 
system.  
Uni-lamellar liposomes resemble biological lipid bilayer membrane structures with 
tunable particle size, surface charge, and composition. Pretreatment with ganglioside-
GM3-containing liposomes inhibited the binding of HIV-1 by dendritic cells, indicating 
an essential role for GM3 in virus binding. To equip the liposome based model systems 
with strong non bleaching optical properties, the membranes were in the next step 
assembled around noble metal nanoparticle core. Noble metal nanoparticles with a size of 
20nm-100nm have extraordinarily large scattering cross-sections and enable prolonged 
tracking of even individual particles with high temporal and spatial resolutions. The 
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plasmon resonance peak of near-field coupled gold nanoparticles red-shifts within 
decreasing interparticle separation. The distance dependent optical properties of noble 
metal nanoparticles were utilized for characterizing clustering levels of breast cancer cell 
marker protein CD24 and CD44 on immortalized cancer cell lines. These encouraging 
results supported the choice of gold nanoparticles as core for multi-modal artificial virus 
nanoparticles. 
Artificial virus nanoparticles combine the biological versatility of a self-assembled 
membrane with the unique optical properties of a nanoparticle core. We developed these 
hybrid materials specifically for the purpose of elucidating key steps of the glycoprotein 
independent binding and uptake of HIV-1 during trans-infection.	  Systematic validation 
experiments revealed that GM3 containing artificial virus nanoparticles (AVNs) 
recapitulate the initial capture and uptake of viruses by sialoadhesin CD169 presenting 
cells. The AVNs also reproduced the tendency of the virus to re-distribute into confined 
cluster spots in cell peripheral areas.	  Upon contact formation between T cell and DC, the 
AVNs developed a polarized distribution in which they enriched at the interface between 
DC and CD4+ T cells.  The multimodality of the AVNs was instrumental in determining 
the detailed location and kinetics of the nanoparticles during the trans-infection process, 
proving the AVN system to be a unique model system to address key mechanistic 
questions in the infection pathway of enveloped virus particles. 
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CHAPTER 1 INTRODUCTION 
1.1 Importance and challenges in virus bio-imaging 
 Since 1898 when the first virus - tobacco mosaic virus - was discovered by 
Martinus Beijerinck (Lecoq 2001), there have been a large number of viruses discovered 
and many of them challenge the human immune system and are causing diseases from 
common cold to cancer. Viruses are small infectious agents that have large diversities in 
size, shape, and dissemination pathways.  
Understanding of viruses has been contributing substantially to virus-disease therapies 
and inspiring versatile industrial usages of virus particles. Insights into virus structure and 
replication strategies create targets for virus control, and further for disease prevention 
and antiviral drugs. The development of vaccines, for example (Mathew 1966), relies 
largely on the understanding of virus - immune system interaction. Knowledge of virus 
properties and behaviors further generate applications in gene delivery, bio-template, and 
even electronics.  
However, although more than 5000 viruses have been described in much detail, the 
diversity of viruses and limitation in detection methods largely impede the progress in 
virus study. (Norrby 2008) (Breitbart and Rohwer 2005) 
Direct visualization of virus behaviors is one of the most effective approaches to obtain 
details and interrogate key questions of virus infection. Combining biological methods 
such as genetically modifying virus properties together with advanced visualization 
techniques such as microscopy, virus structure, infection processes and time scales, 
signaling factors, etc., all become valuable information to be explored thoroughly and 
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precisely(Creager and Morgan 2008). However, most of the viruses have the size ranging 
from 20 nm to 400nm (Kiselev, Sherman et al. 1990), mostly below the diffraction limit 
of visible light and thus are not resolvable under traditional light microscope, let alone 
the intricate and tiny molecular processes happening on them.  
Ultrastructural 3D imaging of viruses reveals fine details of virus structures, virus entry, 
and virus locations inside of cells during infection.(Jones, Shim et al. 2011, Do, Murphy 
et al. 2014) Thin sectioning of properly fixed and stained virus/cell samples enables the 
electron microscopy with high resolution, and compiling these sectioned images produces 
3D structures of the sample with extensive details. Recently Focused Ion Beam (FIB) 
configured with Scanning Electron Microscopy (SEM) has also been applied, in which 
usually Ga ions mill the properly prepared samples by thin layers alternate with SEM 
recording images of the exposed cross sections, and the recorded images are finally re-
constructed to intact structures with good z-resolution. (Risco C. 2014) 
However, as traditional electron microscopy is used in these approaches for high spatial 
resolution, there are high requirements for sample preparation that could cause artifacts 
for the samples. For thin slicing and FIB milling, the samples are already fixed and 
dehydrated, which could have altered from the cellular native states.  
Fluorescent microscopy has been widely used for virus infection study, as a neat 
approach allowing for visualization of samples in original buffers or live cells without 
complicated sample preparation as in traditional electron microscopy. Fluorophore 
labeling is one of the most commonly used approaches that enables tracking of virus 
activities or even single virus tracking. Traditional fluorescent microscopy is limited by 
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diffraction limits of commonly used optical source wavelength and optics. The diffraction 
limit is defined as d = λ!"#$"! , in which d is the smallest focused spot size, λ is the light 
source wavelength, n sinθ is the numerical aperture (NA) of the optics. For current optics, 
the NA could reach up to 1.6. Therefore to image within the visible range (λ ranges from 
400nm to 700nm), the diffraction limit is usually at hundreds of nanometer range. 
Compared with virus sizes that are 20 - 400nm, details can hardly be resolved by 
traditional fluorescent imaging setup due to the diffraction limit. Shortening light source 
wavelengths to below 400nm is not wise as it limits the dye options and samples could be 
destroyed with high-energy illumination. Moreover, the conventionally used organic dye 
or quantum dots usually have problems of bleaching with prolonged illuminating (not for 
quantum dots) or blinking. Continuous observation for long term is hardly achieved. 
High spatial or temporal resolution could be achieved by combining fluorescence tags 
with advanced imaging methods in recent years, in general named super resolution 
microscopy(Huang, Bates et al. 2009, Schermelleh, Heintzmann et al. 2010). Such 
microscopy include Stimulated Emission Depletion microscopy (STED)(Hein, Willig et 
al. 2008), Photoactivated Localization Microscopy (PALM)(Rust, Bates et al. 2006), 4Pi 
microscopy(E.H.K. 1992), Structured Illumination Microscopy (SIM), and so on, some of 
which sacrifice temporal resolution to achieve high spatial resolution, and some of which 
provide imaging output with both high temporal and spatial resolutions.(Brandenburg and 
Zhuang 2007, Abulrob, Lu et al. 2010) The 2014 Nobel Prize in chemistry was awarded 
for super solution fluorescence microscopy, which enables nanoscale imaging with 
optical microscopy.  
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It's never a universal solution for fluorescence microscopy to address every question. 
Even for super-resolution fluorescence microscopy, which breaks the diffraction limit 
and even enables good temporal resolution sometimes, it may require complicated, high-
cost, and sophisticated setups of the microscope. Moreover, it could require special 
labeling of the samples with specific dye molecules, which limits the imaging options for 
multi color tracking. Furthermore, modifications of viruses could potentially alter virus 
properties and may trigger altered virus behaviors, adding complexity to virus infection 
mechanism study.  
Not only the detection method could limit the progress of virus study, but also the virus 
comprise of multiple factors working synergistically to determine the biological 
processes, despite the fact that viruses usually bearing much simpler structures than cells. 
Size, surface charge, surface composition, shape, effective ligands and genetic units, can 
all play a role in virus fate upon meeting the host. Multi-factor functioning together adds 
more difficult to identify key players in each signaling step.  
In conclusion, simple but effective virus models are urgently needed to de-tangle the 
complexity of these biological processes. Virus models that allow single factor 
adjustment, together with superior optical properties will be next options for virus study.  
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1.2 Artificial virus particles in virus research 
 Much effort has been made to engineer smart nanoparticles resembling virus 
features, aiming for structural or mechanistic studies, as well as delivery purposes 
(Mastrobattista, van der Aa et al. 2006, Nap and Szleifer 2013). Successful realizations 
include host produced virus-like particles (VLPs), virus-based NPs, liposomes, and 
hybrid systems in which biomolecules are combined with inorganic nanoparticles to 
reproduce viral functionality.  
For example, host derived virus-like particles (VLPs)(Zeltins 2013) are commonly used 
biological tools to investigate HIV-1 infection process. The presence of virus Gag protein 
can induce the self-assembly and budding of virus-like particles from host cells. The host 
produced virus-like particles have a similar structure of membrane-core structure, except 
that the virus-like particles do not contain any genetic units and thus are not infectious.  
Genetically modification enables expression of eGFP of the virus-like particles, making 
them easily detectable under fluorescence detector. Optical methods can thus be applied 
to the fluorescent VLPs, including flow cytometry and fluorescence microscopy. Virus-
like particles are almost the most similar engineered nanoparticles with virus, and often 
serve as a safe substitution for HIV-1 study.  
To date, more than 110 types of VLPs have been constructed, and widely used to 
investigate functions of viral proteins in virus infection, with the fast development of 
genetic modification techniques to control the expression of certain viral proteins. VLPs 
have also been used as gene delivery and gene therapy tools. Moreover, VLPs with 
fluorescent tags could be easily imaged with fluorescent microscopy, and have provided 
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much valuable insights into virus behaviors including virus entry, virus trafficking inside 
of the cells, and virus cell to cell dissemination pathways.  
However, on the other hand, the VLPs model contains most of the virus-like factors and 
components, such as the envelope membrane proteins and lipid compositions, that work 
synergistically or in cascade to trigger essential signaling to determine particle behaviors 
upon confronting immune systems.  
Although surface components could be modified genetically, not all surface factors could 
be easily tuned and this modification is still limited within certain component species. 
The procedure to create such variations is also usually complicated. Due to multiple 
pathways, some of which are even unknown, could result in the same behavior in some 
cases, the mechanisms could be further obscured.  
The other limitation of VLPs is that the imaging relies on fluorescent detection of the 
genetically expressed fluorescent tag. As mentioned previously, fluorescent imaging 
could be limited of observation time, dye bleaching, or sophisticated setup to achieve 
high resolution.  
Hybrid nanoparticles are also promising candidates for virus study and delivery. Protein 
shell self-assembly around DNA core forms rod-shape virus like particles, and proved its 
capability of protecting of DNA against enzymatic degradation, and its potential as 
delivery vehicles (Hernandez-Garcia, Kraft et al. 2014). Lipid layer wrapping around 
nanoporous silica core produces a virus-like particle named ‘Protocell’, and serves as a 
platform for loading small molecule drugs and short peptides, for effective delivery of 
drugs to cells via particle membrane fusion induced by fusogenic peptides (Mansy, 
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Schrum et al. 2008). Many other hybrid structures have been developed for such purposes, 
(Ashley, Carnes et al. 2011) but none of them fulfill all the specific requirements with 
regard their mechanical property, transducing capability surface composition, 
engineerability to reproduce all the virus behavior robustly.  
An ideal artificial virus nanoparticle should bear features including similarity with virus 
in its structure and surface properties, capability to reliably reproduce virus behaviors, 
and the engineerability to modify one or multiple factors to allow for isolation and 
investigation of interested interactions.(Mastrobattista, van der Aa et al. 2006) 
The aim of this thesis work is to explore advanced artificial virus nanoparticle models 
that could overcome the gaps between similarity with viruses and the functionality of 
probes. Smart nanoparticle models will be designed, fabricated, tested, and evaluated 
with suitable virus infection context.  
 
1.3 HIV-1 trans-infection: concepts and questions 
 Human immunodeficiency virus type 1 (HIV-1) is one of the biggest threatens to 
human immune system. Knowledge about HIV-1 infection pathways has been creating 
opportunities and targets to develop effective vaccines and therapy. 
HIV-1 is the most infectious type of human immunodeficiency virus. It’s roughly 
spherical, with size ranging from 120nm to 150nm in diameter.(Marsh and Helenius 2006) 
The basic structure is shown in Figure 1.1. A host derived envelope membrane containing 
glycoprotein gp120, gp41, and major membrane lipids, is wrapped around the viral 
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capsid core through the linkage of matrix protein. The viral capsid carries 2 single 
stranded RNA.(Kwong, Wyatt et al. 1998) 
 
Figure 1.1 Sketch of HIV-1 structure. 
HIV-1 comprises of a lipid membrane containing envelope glycoprotein (Cyan) and host derived 
lipids (Blue and Red), wrapping around a viral capsid (Purple) through the linkage of matrix 
protein (Pink). Adapted with permission from Yu X et al. Nat Commun. 5:4136 (2014). 
Copyright (2014) Nature Publishing Group. 
 
It has been well recognized that HIV-1 invade macrophages and dendritic cells (DCs) 
through a process called ‘productive infection’ or ‘cis-infection’(Dong, Janas et al. 2007). 
In productive infection, HIV-1 viruses are captured by cell via interactions between 
envelope glycoprotein (gp160) with CD4 and chemokine receptor (e.g. CCR5 or 
CXCR4). The envelope membrane is then fused with the cell membrane mediated by 
gp41, and release the viral capsid carrying viral RNAs. Reverse transcription and 
incorporation of viral RNAs into host genome then lead to production and budding of 
new HIV-1 viruses. (Marsh and Helenius 2006, Wu and KewalRamani 2006) 
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In contrast to this direct infection, HIV-1 is also known to undertake ‘trans-infection’. 
Studies have shown that HIV-1 host derived envelope glycoprotein gp120 can bind to 
dendritic cell specific C-type lectin - DC-SIGN – resulting in the capture and 
internalization of HIV-1 by dendritic cells(Geijtenbeek, Kwon et al. 2000). Instead of 
undergoing the membrane fusion and capsid release, the virus particles are then 
concentrated on dendritic cells, and upon DCs forming conjugates with CD4+ T cells, 
virus particles can be transferred to T cells via virological synapses and induce further 
productive or non-productive infection to T cells. The trans-infection largely enhances 
the efficiency of virus dissemination among cells, and therefore becomes one of the 
important targets for immunization of HIV-1 infection.(Dong, Janas et al. 2007) 
Studies have shown that HIV-1 trans-infection remains effective at the absence of gp120 
and DC-SIGN interaction, indicating the existence of other factors that’s mediating the 
trans-infection. It was then reported that this protein-independent trans-infection could be 
mediated by HIV-1 host derived glycosphingolipids (GSLs). (Gummuluru, Rogel et al. 
2003, Izquierdo-Useros, Naranjo-Gomez et al. 2009, Waheed and Freed 2010) (Figure 
1.2). 
 GSLs make up around 5% of the total membrane lipid composition of HIV-1 and are 
highly enriched in lipid rafts as well as in HIV-1 particles as they bud from the host cell. 
There are many GSL variants, and are classified as gangliosides, a sialogangliosides, and 
globosides. Gangliosides have a sialic acid head group, while none of the other GSL 
subsets are sialylated. However, due to the lack of suitable approaches and tools, the 
exact factors that are responsible for the GSL dependent process remain unclear, and the 
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detailed mechanisms remain intriguing. Which glycosphingolipids are mediating the 
virus capture? What counterparts on DCs are interacting with the viruses? What signaling 
pathways will then happen to protect the viruses against traditional productive infection 
pathway and lead to the re-distribution of the viruses? Where do the viruses exactly 
locate after being concentrated on DCs? What’s the time scale and driving force of the 
virus concentration, and what is mediating the further transferring of viruses into CD4+ T 
cells?  
A series of such questions arise, and we believe an adequate artificial virus nanoprobe 
will help to clarify the mystery of the lipid-independent trans-infection.  
 
 
Figure 1.2 HIV-1 trans-infection mediated by glycosphingolipid (GSL). 
HIV-1 virus (1) can be captured by mature dendritic cells (2) and concentrated on dendritic cells. 
Upon forming virological synapse between DC with CD4+ T cell, viruses can then be transferred 
to T cells efficiently. 
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CHAPTER 2 LIPOSOME TARGETING ON HIV-1 TRANSINFECTION 
2.1 Liposome nano-probe design, synthesis, and characterization  
2.1.1 Liposome design 
Liposomes, first described by Alec Bangham in 1965,(Bangham, Standish et al. 1965) 
comprise of the lipid bilayers and an inner aqueous volume. Liposomes could be self-
assembled in aqueous solution due to hydrophobic interaction between alkyl chains of 
lipids. Multi-lamellar liposomes are liposomes with multiple lipid bilayers, with sizes 
ranging from tens of nanometers to microns. (Hope, Bally et al. 1985)  
Uni-lamellar liposomes have only one lipid bilayer, and thus have a much larger 
core/shell ratio, a better-defined membrane composition, and a simpler internal structure 
than multi-lamellar liposomes. Both multi-lamellar and uni-lamellar liposomes have been 
widely used as drug delivery carriers, as hydrophobic molecules could be loaded into the 
lipid layers, and water-soluble molecules could be loaded into the interior aqueous cargo.  
How the liposomes interact with cell surfaces, and the fate of these liposomes in vivo 
thus became crucial questions for molecular chemists to explore. Rahman et al. studied 
the effects of liposomes’ size, charge, as well as compositions on the liposome-
macrophage binding process and the subsequent uptake. Papahadyopoulos studied the 
endocytosis of liposomes by macrophages. (Schwendener, Lagocki et al. 1984, Daleke, 
Hong et al. 1990)These studies, which were aimed at improving drug delivery efficiency 
of liposomes, inspired us to use liposomes as functional probes to study virus behaviors. 
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Designing of the liposome probes are the most important prerequisites. The liposome size, 
composition, charge ligand concentration, all need to be adjusted according to the 
specific system of interest. 
To verify the host derived glycosphingolipids (GSLs) are responsible for HIV-1 trans-
infection, liposomes here are designed to mimic the HIV-1 envelope membrane that’s 
free of glycoproteins.  
As shown in Figure 2.1, compared with HIV-1 envelope membrane on the left, a uni-
lamellar liposome is designed on the right panel. The HIV-1 membrane lipid composition 
has been reported to contain 45.1mol% cholesterol, 8.8mol% phosphatidylcholine (PC), 
4.4% phosphatidylethanolamine (PE), 14.8% plasmalogen-PE (Pl-PE), and 8.4% 
phosphatidylserine (PS). (Brugger, Glass et al. 2006). Our liposome model simplifies the 
lipid composition to only dipalmitoylphosphatidylcholine (DPPC) (53 mol%), cholesterol 
(45 mol %). 1 mol % PS is added to adjust the liposome surface charge to be similar with 
the virus. The last 1 mol % lipid specie varies, to generate liposomes with different 
ligands for further investigation. 0.1% of cholesterol-bodipy is doped into the membrane 
to provide fluorescent tag for the probe. When 1mol% DPPC was added, i.e. there’s 
54mol% DPPC total, the liposome is herein referred to as ‘blank’ liposome; when 1mol% 
α2–3-linked gangliosidesmonosialodihexosylganglioside (GM3) or GM1, or core 
phospholipid ceramide, galactosyl ceramide, or tetrasialoganglioside GQ1b are added to 
the liposome respectively, the liposomes are then referred as ‘GM3’, ‘GM1’, ‘Cer’, ‘Gal’, 
or ‘GQ1b’ respectively.(Puryear, Yu et al. 2012) 
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Figure 2.1 Design of liposome nanoprobe. 
HIV-1 cross-section structure is shown on the left panel, containing a lipid bilayer, and an inner 
capsid. The HIV-1 membrane major components are listed under the sketch. The liposome model 
is sketched on the right panel, containing only HIV-1 membrane major lipid species and GSL of 
interest. 
 
2.1.2 Liposome fabrication 
Traditionally liposomes can be generated by dispersing lipid molecules in aqueous 
buffers. Further modification steps improve the quality of liposomes. Sonication and 
freezing-thaw cycles are used to generate uni-lamellar liposomes. (Castile and Taylor 
1999) (Mayer, Hope et al. 1985)  Other methods such as reverse-phase evaporation have 
also been used to generate uni-lamellar liposomes. 
Liposomes with the compositions described in 2.1.1 are fabricated with previously 
reported method with some modifications. 
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500nmol lipid mixture is firstly dissolved in chloroform in a 25ml round bottom glass 
flask, and vacuum dry to form a thin lipid dry layer. 1ml Phosphate buffered saline 1x is 
added to the flask and vigorously agitated to form a cloudy solution. The suspension is 
then sonicated for 1h at 60˚C under Ar protection (0.5Watts), and go through 5 cycles of 
freezing-thaw with liquid nitrogen and the 60˚C water bath. The sonicated liposome 
solution is then extruded through 80nm-diameter pore sized polystyrene membrane 11 
times to reach a homogeneous size distribution. The sonication and the extrusion turn the 
cloudy multi-lamellar liposome solution into clear uni-lamellar liposome solution, which 
is observed vividly during the process. The Ar protection prevents the active bio-
molecule from oxidation during sonication. 
2.1.3 Liposome characterization 
The above synthesized liposomes are then carefully characterized prior to use.  
The sizes of the fabricated liposomes are measured by Malvern Zetasizer ZS90 as shown 
in Table 2.1. Most of the radii of the liposomes are around 120-130nm.d, with very sharp 
size distributions (polydispersity Pdi< 0.1). 
 
 Ave/r.nm Peak/r.nm Width/nm Pdi 
Blank 57.74 61.04 14.46 0.053 
Gal-Cer 65.03 70.92 21.78 0.070 
GM1 64.62 69.45 18.72 0.070 
GM3 67.16 72.57 20.76 0.069 
GQ1b 62.31 69.31 22.56 0.098 
 
Table 2.1 Size distribution of liposomes. 
Blank liposomes, 1% Gal, 1% GM1, 1% GM3, 1% GQ1b liposomes have sizes of around 
130nm.d. All sizes have sharp distributions with Pdi< 0.1.  
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Surface charge of liposomes is measured as surface zeta potential, using Malvern 
Zetasizer ZS90 at pH=8.0, 25˚C. Gap-eGFP virus-like particle (free of envelope protein) 
is used as a reference control, measured under the same condition. 
Results show that for VLP, zeta potential is -26.6 mV at pH=8.0, 25˚C, while for blank 
liposome, 1% Gal, 1% Cer, 1% GM3, 1%GM1, 1%GQ1b liposomes, their zeta potentials 
are -33.3mV, -27.4mV, -21.4 mV, -35.3mV, -22.0mV, -31.9 mV respectively. The 
surface charges are thus controlled at the same level and similar with the VLP membrane 
surface charge level. 
Negative staining of 1% GM3 liposomes and air drying on copper grid enable the 
inspection of liposomes under transmission electron microscope (TEM). Figure 2.2 
shows the deposited liposome TEM images.  
 
 
Figure 2.2 TEM image of 1% GM3 liposomes. 
Liposomes were negative stained with uranyl acetate and deposited onto copper TEM grid. 80kV 
was used to image the air dried liposome sample. 	  	  
200nm 
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Concentrations of liposome solutions are calculated basing on the proportional increase 
of scattering intensity with the number concentration for the same sized liposomes. 
Briefly, the Malvern Zetasizer ZS90 has the function to calculate the number 
concentration based on the scattering intensity given the size of the scatterer. Liposome 
solution is then serial diluted and measured for their scattering intensity respectively. 
After plotting the intensity vs. dilution factor, the machine estimated number 
concentration for one certain intensity is taken into the fitted function, in which way a 
dilution factor vs. number concentration will be derived. The raw solution concentration 
will be the number concentration calculated for dilution factor is 1.  
This concentration measurement method was tested with standard polystyrene beads with 
known concentration and proved to be working with little error. 
With the careful characterization of synthesized liposomes, the liposomes are then ready 
to be tested in the HIV-1 lipid mediated trans-infection model. 
2.2 Application of liposomes to HIV-1 trans-infection study 
Mature DCs were challenged with equal amounts of each type of liposomes, to test the 
binding efficiency of each GSL species. The binding level was measured by flow 
cytometry which is enabled by fluorescent tag in liposome membrane layers. Briefly, 
5x107 of each type of liposomes were added to 2x105 DCs respectively, and incubated at 
37˚C in raw RPMI medium for 1h. Cells were then washed by centrifugation twice to 
remove excess liposomes, and fixed with 4% paraformaldehyde solution for 15min at 
room temperature, and bring to flow cytometry for binding measurements. 
Results are shown in Figure 2.3. 
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Figure 2.3 Binding level of liposomes on mDCs. 
Liposomes binding levels on mDCs, and mean fluorescence intensity was recorded by flow 
cytometry, and normalized to Blank liposome binding level. Figure adapted with permission from 
Puryear W.B. et al. PNAS, 2012, Vol 109, p.7475-7480, Copyright (2012) National Academy of 
Sciences, USA 
 
Mean Fluorescence Intensity (MFI) were recorded and normalized to Blank liposomes 
binding levels. The data were obtained from at least 3 donors, and shown with the 
averaged binding value. As can be seen from the figure, while the Blank, Cer, Gal and 
GQ1b liposomes all bind to the baseline level, the GM3 and GM1 liposomes bind more 
than 2 folds higher than others, indicating of the positive effect of GM3 and GM1 in 
liposome capture by mDCs. The bindings were proved to be significant by one sample 
student t test, p<0.001. GM3 binding level is higher than GM1 is observed as well. 
To prove the GM3 and GM1 are the only factors that function in the virus capture by 
mDCs in lipid dependent trans-infection pathway, competition assay was carried out. The 
mDCs were pretreated with 0.1% sodium azide to prevent membrane recycling and 
internalization of the liposome. mDCs were then incubated with each type of liposomes 
respectively.  
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After 1h incubation, free unbound liposomes were removed by centrifugation, and 
samples were then challenged with HIV-1 viruses that are modified to be glycoprotein 
free (HIVLaiΔEnv), as well as VLPs that do not contain glycoproteins (Gag-eGFP). As 
predicted, Figure 2.4 shows that, for GM3 or GM1 liposome treated DCs, the binding 
level of HIVLaiΔEnv dropped to 30% of Blank liposome treated samples at 109 liposome 
dosage. Similarly, the binding level of Gag-eGFP dropped even lower for GM3 or GM3 
liposome treated samples. Since both HIVLaiΔEnv and Gag-eGFP are showing inhibited 
binding by mDCs after GM3 or GM1 treatments, and both of them lack the glycoprotein 
which could otherwise mediate the capture, it is confirmed again here, that the GM3 and 
GM1 molecules are essential factors for initial capture of viruses by mDCs.  
Moreover, since GM3 and GM1 are tested separately in these assays, we can conclude 
both of them can play a role in this process even at the absence of each other. 	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Figure 2.4 Competition assay of liposomes. 
Blank, GM3, GM1, Gal, GQ1b liposomes are used to block the virion binding site on mDCs. 
HIVLaiΔEnv inhibition levels are shown in the left penal, while the Gag-eGFP inhibition levels 
are shown on the right. Figure reprinted with permission from Puryear W.B. et al. PNAS, 2012, 
Vol 109, p.7475-7480, Copyright (2012) National Academy of Sciences, USA 
 
In conclusion, the application of liposomes with different GSL species has confirmed that 
the host derived GM3 and GM1 are the molecules that initiate the binding with mDCs in 
lipid-dependent trans-infection process. 
 
2.3 Advantages and disadvantages of liposomes 	  
Liposomes have shown strong similarity with virus envelope membrane structures, with 
tunable size and surface charges. It’s remarkable how liposomes can simplify the 
complicated biological entity as viruses down to a membrane structure with the existence 
of solely the target molecules to be studied. GM3 and GM1 are lipids that are not 
completely soluble in aqueous solution, making their interaction with cells directly hard 
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to implement. Although theoretically a similar conclusion could be drawn by using a 
GM3 or GM1 containing polymer or other carriers, liposomes carrying GM3 or GM1 
could exclude the effects resulted from the difference in surface charge, surface 
composition, and surface mechanical properties, which are hardly achieved by 
polystyrene or polymer cargos.  
The design, fabrication and characterization are all done in a non-complicated way, and 
the test with cells is straightforward, simple and fast.  The isolation of individual 
parameter enables precise targeting on the interested factor, making the liposomes a 
promising platform to investigate ligands, size, and surface charge’s effects separately. 
(Puryear, Yu et al. 2012) 
However, on the other hand, liposomes have many limitations as smart nanoprobes. With 
the interior space filled with aqueous solution, liposomes do not have a support for its 
membrane as compared to virus, whose viral capsid and matrix protein provide sufficient 
support to the envelope membrane. This results in the difference in particle mechanical 
stiffness and will then affect the response for cell membranes to interact with the 
nanoprobe, for example, the energy for the membrane to undertake morphology change 
to accommodate for further particle uptake will be very different for ‘soft’ particles than 
‘stiff’ particles.(Kol, Shi et al. 2007) To extrapolate the situation to downstream cellular 
behaviors, the liposomes could deviate from the expected virus behavior largely due to 
the property difference with real viruses. Liposomes are thus difficult to become an ideal 
artificial virus nanoparticles, but only serve as simplified models for viral membrane 
study. 
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Another limitation lies in the optical property of the liposome nanoprobes, which largely 
based on the fluorescent tag that was incorporated into the membrane. The commonly 
used fluorescent tag is organic dye that’s conjugated to lipid molecules. Therefore the 
detection of liposomes totally based on fluorescent microscopy. As mentioned earlier, the 
blinking and bleaching problems with the organic dye limits the long term tracking of the 
nanoprobes, and temporal resolution is often sacrificed to obtain high spatial resolution as 
in the case of some super-resolution fluorescent microscopy such as stochastic optical 
reconstruction microscopy (STORM). The fluorescence based optical property largely 
impedes the application of liposomes as live-tracking agents.  
In conclusion, despite of the fact that liposomes have performed as an adequate virus 
membrane model and provided valuable information regarding initial steps of HIV-1 
lipid-dependent trans-infection, liposomes can hardly fulfill the requirements to serve as 
an ideal artificial virus nanoparticle due to virus-similarity and detection methods.
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CHAPTER 3 COLLOIDAL GOLD AS BIO-IMAGING NANO-PROBES 
3.1 Optical properties of colloidal gold nanoparticles (AuNPs) 
Noble metal nanoparticles such as gold and silver have been recognized as excellent 
optical nanoprobes due to their brightness and distinguishable colors. Coherent collective 
oscillation of the conduction band electrons of these noble metal nanoparticles results in a 
phenomenon called ‘plasmon’. (Kreibig 1995) 
When the incident light wavelength is much larger than the particle size, the dipole mode 
will dominate the light-nanoparticle interaction, and the electromagnetic field of the 
incident light can interact with the nanoparticle strongly that a coherent collective 
oscillation of conduction band electrons happens at a specific frequency (the resonance 
frequency), resulting in an enhanced electromagnetic field, and thus the scattered light at 
the resonance frequency will be enhanced, which is defined as ‘plasmon resonance’. 
(Eustis and el-Sayed 2006) (Marier 2007) 
Clausius-Mossotti relation gives polarizability of a nano sphere as follows: 
 
It relates the polarizability with the size of the nano sphere R as well as the dielectric 
constant of surrounding medium εm and the dielectric constant (frequency ω dependent) 
of the metal. ε0 is the vacuum permittivity. When ε(ω) = -2εm the polarizability reaches 
maximum.  
The dielectric constant of medium εm is positive, while noble metals such as gold and 
silver have dielectric function ε(ω)= ε1(ω)+ i ε2(ω) negative for ω in the visible 
frequency range, which satisfies the resonance condition in visible range. Moreover, the 
23	  	  
	  
decay of the electron oscillation occurs in radiative and nonradiative ways, the former 
part emits photons, and the latter part result in absorption and dissipation. Showing by 
equations, the cross-section of the scattering of the particle is 
 
and the cross-section for absorption is  
 
with k being the incident light wavenumber. As can be seen, for noble metal spheres with 
radius R larger than 20nm, the scattering cross-section is extremely large and the particle 
has huge elastic scattering efficiency compared with similar sized scatterers. (Marier 
2007) This largely facilitates the easy detection of the nanospheres under dark-field 
microscope. 
It could also be seen from the equations, that plasmon resonance wavelength could be 
affected by the size of the nanoparticle. For example, for gold nanoparticles larger than 
20nm, the wavelength shifts larger along with the particle size, although in a small scale. 
Besides, the resonance wavelength also shifts with the particle shape, particle 
composition, and dielectric of the environment. (Jain, Lee et al. 2006) (Murphy, Sau et al. 
2005) 
Another useful property of the noble metal nanoparticles is the distance dependency of 
the plasmon resonance peak wavelengths. (Su 2003). For nanoparticles that approach 
each other, plasmon coupling between nanoparticles separated by less than about 2.5 
24	  	  
	  
times of NP diameter leads to a measureable spectral red-shift of the plasmon resonance, 
and therefore, facilitates the detection of NP clusters in a cellular context both through 
elastic or inelastic light scattering. Figure 3.1 shows the illustration of the distance 
dependency of plasmon resonance peak wavelengths. The magnitude of the spectral 
plasmon resonance shift upon NP clustering depends on the separation between the NPs, 
the number and geometric arrangement of interacting NPs, and the ambient refractive 
index, nr.  
The cluster size and separation dependence of the scattering spectra of NP immunolabels 
at constant nr forms the foundation for characterization the spatial organization of cell 
surface moieties on nanometer to tens of nanometer length scales through spectral 
analysis of collective NP responses in plasmon coupling microscopy (PCM). (Kreibig 
1995, Sonnichsen, Reinhard et al. 2005) 
 
Figure 3.1 Resonance peaks shift along with interparticle distance.  
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For AuNPs illuminated by incident light approaching each other, the dipole-dipole interaction 
results in the plasmonic resonance frequency change, and the resonance wavelength shifts to red 
when the two particles' distance shortens. Here the DNA spacer length indicates the interparticle 
distance (in bps). Reprinted with permission from Reinhard et al, Nano Lett. 2005, 5(11), pp 
2246-2252. Copyright (2005) American Chemical Society. 	  
The optical response of AuNP immunolabels is dominated by particle plasmons, and their 
large optical scattering cross section makes individual AuNPs with diameters larger than 
20nm can be visualized in darkfield or differential interference contrast (DIC) 
microscopy. (Gu, Di et al. 2012) 
Due to the optical property is based on scattering, the scattered light will be free of 
problems that usually happen to organic dyes, such as blinking or bleaching. Combining 
the electromagnetic field interaction between NP labels, which provide spatial resolution 
down to nanometer or tens of nanometer ranges, AuNPs are thus promising candidate for 
bio-imaging for prolonged observation, fast-tracking with both high spatial and temporal 
resolution. To further test the superior optical properties of AuNPs as potential building 
blocks for artificial virus nanoparticles, the AuNPs were applied to detect cancer marker 
protein clustering levels first. 
 
3.2 Detection of cancer marker protein CD24/44 clustering levels with AuNPs 
3.2.1 Introduction 	  
The lateral organization of CD24 and CD44 plays an important role for their functionality. 
While the glycosyl-phosphatidylinositol (GPI) linked sialo-protein CD24 is believed to 
preferentially localize in lipid rafts(Sharma, Varma et al. 2004) where it can affect the 
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spatial distribution of other membrane components, CD44 has been characterized as a 
temporary raft residing protein whose translocation into lipid rafts can induce the 
formation of local signaling ‘hot-spots’. (Oliferenko, Paiha et al. 1999) A direct 
experimental verification of the selective enrichment of CD24 in lipid rafts is challenged 
by the small sizes of these domains, which are typically smaller than the resolution limit 
of conventional light microscopy (about 250nm).  
We demonstrate here that 40nm diameter Au immune-labels targeted at CD24 and CD44 
do not only facilitate a rapid detection of CD44 and CD24 over expression at the single 
cell level but also enable a quantitative characterization of the self-organization 
(‘clustering’) of the proteins on the tens of nanometer length scale, resulting in a more 
complete characterization of cellular phenotypes. Since the clustering of cellular surface 
protein plays an important role in the spatial regulation of signaling and cell-to-cell 
communication,(Simons and Toomre 2000) (Wang, Yu et al. 2012) the gain in 
information about the spatial organization of disease relevant surface proteins, such as 
CD24 and CD44, has tangible diagnostic and therapeutic implications. 
Here we applied an all-optical approach to characterize the spatial distributions of CD24 
and CD44 after immobilization in the plasma membranes of the in vitro breast cancer cell 
lines MCF7 and SKBR3.(Yu, Wang et al. 2013) 
3.2.2 Synthesis and characterization of immuno-labelled AuNPs 
AuNPs are immune-labelled with anti-biotin antibody or Neutravidin as reported 
previously(Wang, Boriskina et al. 2011, Wang, Yu et al. 2012) and illustrated in Figure 
3.2. 
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Figure 3.2 Sketch of immune-labelling of AuNPs. 
For Neutravidin functionalized gold nanoparticles, the antibiotin antibody was substituted by 
Neutravidin. Reprinted with permission from Yu et al. Anal Chem 2013 85 (3), pp. 120-1294. 
Copyright (2013) American Chemical Society. 	  
Briefly, 5ul of 10mM thiol-PEG-azide solution (Nanocs, MW 3400) was incubated with 
40nm AuNPs (TedPella, ~9x10 particles/mL) overnight at room temperature, followed by 
three centrifugation (5500rpm, 10min) washing steps using distilled deionized (ddi) water. 
In the meantime, 2uL of 100mg/mL propargyl-PEG-HNS ester (Quanta design) DMSO 
solution was mixed with 100uL of 1mg/mL anti-biotin antibody (Sigma-Aldrich) in 1x 
PBS (pH 7.2) in ice-bath for 6 hours. Excess propargyl-PEG-NHS ester was removed 
using a 7K MWCO size exclusion column. 100uL propargyl-PEG-anti-biotin antibody 
was then incubated with 20uL PEG-AuNPs in the presence of click chemistry catalyst (a 
mixture of 100 nmol ascorbic acid and 20 nmol CuSO4 in ddi water) at 4ºC for 8 hours. 
The particles were then washed three times by centrifugation (4500rpm, 10min, ddi 
water), resuspended in 0.5x PBS, pH 7.2, and used immediately afterwards. Neutravidin 
functionalized Au-NPs were obtained using the same approach but replacing anti-biotin 
antibody with Neutravidin. 
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The functionalized AuNPs were purified by centrifugation and stored at 4ºC for further 
characterization and cell experiments. 
Dynamic light scattering measures functionalized AuNPs to be uniformly distributed with 
sizes around 60nm.d, shown in Figure 3.3. UV-VIS spectra of functionalized AuNPs are 
also shown in Figure 3.4. Neutravidin particles and antibiotin before and after incubation 
with cells are all shown in the figure, confirming the nice dispersity and stability of the 
particles even after cell experiments, proving the particles are stable against spontaneous 
self-association under the chosen cell experiment conditions. 
 
 
Figure 3.3 Size distribution of functionalized AuNPs. 
The figure shows the size distribution by scattering intensity of Neutravidin particles and 
antibiotin particles, before and after incubation with cells. Reprinted with permission from (Yu et 
al. Anal Chem 2013 85 (3), pp. 120-1294). Copyright (2013) American Chemical Society.  
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Figure 3.4 UV-VIS spectra of Neutravidin AuNPs and antibiotin AuNPs. 
The figure shows spectra of AuNPs both before and after incubation with cells. Reprinted with 
permission from (Yu et al. Anal Chem 2013 85 (3), pp. 120-1294). Copyright (2013) American 
Chemical Society. 	  
The functionalized AuNPs are then ready for cell protein marker labeling. 
3.2.3 Probing CD24/44 clustering levels with AuNPs 
SKBR3 cell were cultured in McCoy medium supplemented with L-glutamine, penicillin 
and streptomycin in a 5% CO2 containing atmosphere at a relative humidity of 95% at 
37˚C. MCF7 cells were cultured in EMEM medium supplemented with 0.1% insulin, L-
glutamine, penicillin and streptomycin under the same conditions. Cells to be 
immunolabeled were seeded either on glass coverslips or silicon substrates, and were 
grown to approximately 30% confluency. 
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The glass coverslips or silicon chips containing SKBR3 or MCF7 cells were briefly 
rinsed with 10ml 1x HBSS buffer at 37˚C. The cells were then fixed by immersion in 4% 
formaldehyde solution for 10min at room temperature, followed by 3 times of immersion 
into ice-cold 1x PBS for 5 min. Subsequently, the cells were blocked by incubation with 
1% BSA at 4˚C in 1x PBS for one hour. 
Primary antibodies against CD44 or CD24 were diluted to 1:1000 in 1x PBS, then 
applied onto the cell slides prepared above. After incubation for overnight at 4˚C, the 
cells were washed 3 times by ice-cold 1xPBS for 5min each. The biotin-labeled 
secondary IgG antibody (1:1000 in 1xPBS) was added and incubated for 1h at room 
temperature. After 3 times of washing with ice-cold 1xPBS the cells were ready for NP 
immunolabeling. 
400ul of the functionalized AuNPs were incubated with each cell slide for 3 hours at 
room temperature in a water-vapor-saturated atmosphere. Then the cells were rinsed with 
copious amounts of ice-cold 1xPBS for 3 time. 
The labeling process is illustrated in Figure 3.5 as shown below. 
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Figure 3.5 Sketch of cell protein marker labeling strategy. 
Reprinted with permission from (Yu et al. Anal Chem 2013 85 (3), pp. 120-1294). Copyright 
(2013) American Chemical Society. 
 
The samples on glass coverslips were ready for optical inspection in the microscope after 
covering with a glass coverslip. The samples on silicon substrates were briefly immersed 
into ddi water to remove the salt on the surface, and then gently blow dried in a nitrogen 
stream. The samples were immediately imaged via Scanning Electron Microscopy (SEM). 
To check the stability of the NP immunolabels under the chosen experimental conditions, 
we collected the functionalized NP immunolabels after their incubation with the cells and 
randomly deposited them onto a clean glass slide for 1min. Then, the surface 
immobilized NPs were washed by rinsing with copious amounts of ddi water, after which 
a 51% glycerol solution with nr =1.40 was applied onto the NPs. This refractive index 
was chosen as average of the refractive indices of water and lipid membranes to simulate 
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the ambient medium at the water/lipid bilayer interphase. For the preparation of SEM 
samples the controls were prepared on silicon substrates in the same way but the addition 
of glycerol solution was omitted. 
Results show that the developed NP immunolabels efficiently bound to their protein 
targets and indicated CD44 or CD24 overexpression by a vivid coloring of the labeled 
cells (Figure 3.6). The NP labeling experiments confirm the CD44+/CD24+ phenotype 
for MCF7 and CD44−/CD24+ for SKBR3, which is consistent with flow cytometry 
measurements (Figure 3.7) and recent reports. (Calcagno, Salcido et al. 2010) 
 
Figure 3.6 Immuno-labelled AuNPs labeling CD24 and CD44 on MCF7 and SKBR3 cells 
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Dark-field scattering images of SKBR3 cells labeled for (a) CD44 and (b) CD24 and MCF7 cells 
labeled for (c) CD 44 and (d) CD24. Scale bars are 5 µm. Reprinted with permission from (Yu et 
al. Anal Chem 2013 85 (3), pp. 120-1294). Copyright (2013) American Chemical Society. 	  
 
Figure 3.7 Expression levels of CD24/44 on MCF7 and SKBR3 cell lines. 
Characterization of expression levels of CD24 and CD44 on MCF7 and SKBR3 cell lines via 
flow cytometry. MCF7 cells overexpress both CD24 and CD44. SKBR3 cells only overexpress 
CD24. The expression level of CD44 is low. Reprinted with permission from (Yu et al. Anal 
Chem 2013 85 (3), pp. 120-1294). Copyright (2013) American Chemical Society. 	  
A close inspection of the darkfield scattering images of SKBR3/CD24, MCF7/CD24, and 
MCF7/CD44 (Figure 3.8 a-c) shows that the NP labeling leads to a discrete spotting of 
the cell surface, where each spot belongs to one or several NPs. Taking advantage of the 
strong distance dependence of plasmon coupling on a length scale of up to approximately 
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one NP diameter, additional information about the number and spatial distribution of NPs 
within individual diffraction limited spots can be obtained through analysis of their 
spectra. A color that is significantly red-shifted relative to the vivid green of individual 
Au NPs indicates a local clustering of the labels. The magnified views of NP labeled 
SKBR3/CD24, MCF7/CD24, and MCF7/CD44 cell surfaces in Figure 3.8 a- c show that, 
consistent with locally varying degrees of NP clustering, all cell/protein combinations 
exhibit a heterogeneous distribution of colors.  
In Figure 3.8 d-e, we show a section of the NP labeled MCF7/CD24 sample at an even 
higher magnification and a randomly chosen scanning electron microscope (SEM) image 
of the same sample. Both images confirm the heterogeneous distribution of the NP labels 
and their organization into discrete clusters. While the 40 nm NPs used in this work are 
too large to assume targeting of individual surface proteins, the observed NP 
immunolabel clusters indicate membrane domains with lateral dimensions of tens to 
hundreds of nanometers that are enriched in target proteins due to the large-scale 
organization of the proteins in the membrane.  
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Figure 3.8 AuNP clustering upon binding on cell surfaces. 
Au NP immunolabels form discrete spots on the cell membrane for different cell/protein targets: 
(a) SKBR3/CD24, (b) MCF7/CD24, and (c) MCF7/CD44. The magnified view in (d) further 
emphasizes the “spotting” after labeling with NPs. (e) SEM imaging confirms the organization of 
the cell-bound NPs into clusters of varying sizes (here for MCF7/CD24). (f) Exemplary spectra of 
individual spots on the cell surface. Size bars are 5 µm for (a−c) and 1 µm for (d−e). Reprinted 
with permission from (Yu et al. Anal Chem 2013 85 (3), pp. 120-1294). Copyright (2013) 
American Chemical Society. 	  
To further characterize and compare CD24 and CD44 clustering on MCF7 and SKBR3, 
we recorded elastic scattering spectra of ∼200 randomly chosen NP spots for each 
cell/protein concentration and determined the peak wavelengths (λres) of the measured 
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spectra (Figure 3.8 f). The experimental setup and the spatially resolved data acquisition 
approach are illustrated in Figure 3.9 and described previously.  
 
Figure 3.9 Dark-field imaging and spatially resolved spectrum acquisition setup. 
The NP labeled cell surfaces were illuminated by a tungsten light source (100W) via a dark-field 
oil condenser (NA = 1.2-1.4). The microscope was equipped with a 100X oil objective (NA=0.6). 
Scattering images were collected through an eyepiece adapter using an Olympus SP310 digital 
camera. After identification of individual scatterers on the cell surface in the recorded images, 
scattering spectra of selected emitters were recorded using an Andor spectrometer connected to 
the microscope. A controllable entrance slit in combination with the spectrometer acquisition 
software allowed the selection of individual scatterers for data acquisition. The entrance slit of the 
spectrometer was set to 2µm. Reprinted with permission from (Yu et al. Anal Chem 2013 85 (3), 
pp. 120-1294). Copyright (2013) American Chemical Society. 	  
The resulting λres distributions of MCF7/CD44, SKBR3/ CD24, and MCF7/CD24 are all 
significantly (p < 0.001, 2-side Student’s t test) red-shifted (Figure 3.10 a) when 
compared with the λres distribution of randomly distributed Au NP immune-labels 
immersed in a glycerol solution with refractive index of nr = 1.40. This comparison 
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indicates that the spatial CD24 and CD44 distribution induces the NP clustering on the 
cell surface. We did not include SKBR3/CD44 in this analysis, as the binding was too 
low (Figure 3.6 a). The average resonance wavelengths (λav ± standard deviation) for 
CD24 on SKBR3 and MCF7, respectively, are λav = 555.4 ± 4.6 nm and 558.5 ± 7.8 nm 
and for MCF7/CD44 is λav = 553.6 ± 7.4 nm, which is compared with λav = 547.4 ± 4.0 
nm for the Au NP control. The observed shifts in the λres distributions in Figure 3.9 a 
show that the CD24 labeled cells contain more clusters with more strongly coupled NPs 
than that observed for CD44 (p < 0.001 for MCF7/CD24 and MCF7/CD44). This finding 
is consistent with a stronger clustering of CD24 in the plasma membrane. We emphasize 
that the clustering of CD24 and the spatial separation between the clusters observed in 
Figure 3.8 d-e is in good agreement with previously observed distribution patterns of 
cholesterol enriched domains using super resolution fluorescence microscopy. 
 
Figure 3.10 Characterization of NP clustering through spectral analysis. 
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Cumulative distribution plots of the fitted peak resonance wavelength (λres) of 40 nm Au NPs in 
an ambient refractive index of nr = 1.40 and targeted at CD24 and CD44 on MCF7 and SKBR3 
cells in HBSS. (b) Cumulative distribution plots of λres for NPs targeted at MCF7/CD24 before 
(red) and after (blue) treatment with m-β-CD. For each individual condition, approximately 200 
individual measurements were evaluated in (a) and 400 in (b). Reprinted with permission from 
(Yu et al. Anal Chem 2013 85 (3), pp. 120-1294). Copyright (2013) American Chemical Society. 	  
Histograms of the fitted peak resonance wavelengths are shown in Figure 3.11 
 
Figure 3.11. Distribution of cluster peak wavelengths of AuNPs. 
a) NP immunolabels targeted at (top to bottom) SKBR3/CD24, MCF7/CD24, MCF7/CD44 and 
randomly deposited NPs covered with a glycerol solution (nr = 1.40), and b) NP immunolabels 
targeted at MCF7/CD24 before (top) and after (bottom) treatment with beta-cyclodextrin. The 
histograms show that both CD24 and CD44 are organized into clusters (indicated by the red-
shifted peak wavelengths) on MCF7 and SKBR3 and that CD24 tends to form larger clusters than 
CD44. The blue-shift in the spectra of MCF/CD24 after treatment with beta-cyclodextrin in b) is 
consistent with a removal of the preferential CD24 clustering upon lipid raft disruption due to 
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cholesterol sequestration. Reprinted with permission from Yu et al. Anal Chem 2013 85 (3), pp. 
120-1294. Copyright (2013) American Chemical Society. 
 
We validated the findings of our optical measurements by analyzing the clustering of NP 
labels targeted at CD24 and CD44 on MCF7 cells through SEM in Figure 3.12 a. We 
analyzed the association of NPs into clusters for a total of 1500−2500 NPs on 13 cell 
surfaces obtained in 2 independent labeling experiments for each cell/protein pair. We 
also included the distribution obtained for antibiotin functionalized NP immunolabels 
(recovered from solution after incubating with the cells) randomly deposited on the 
substrate as control to verify the stability of the NP immunolabels under the chosen 
experimental conditions.  
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Figure 3.12 SEM characterization of NP cluster size distributions. 
Size distribution of (a-i) randomly immobilized Au NP immunolabels collected after incubation 
with cells, (a-ii) Au NPs targeted at CD44 on MCF7 cells, and (a-iii) Au NPs targeted at CD24 on 
MCF7 cells. (b) Neutravidinfuntionalized Au NP cluster size distributions before (b-i) and after 
(b-ii) m-β-CD treatment of MCF7/CD24. Reprinted with permission from Yu et al. Anal Chem 
2013 85 (3), pp. 120-1294. Copyright (2013) American Chemical Society. 	  
The numerical percentages of each section are summarized in Tables 3.1 and Table 3.2. 
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Table 3.1 Cluster size distributions of CD24/44 on MCF7 and SKBR3 cells. 
For each cell line/receptor combination, 1500-2500 particles were evaluated from 13 randomly 
chosen cell samples using SEM. Reprinted with permission from (Yu et al. Anal Chem 2013 85 
(3), pp. 120-1294). Copyright (2013) American Chemical Society. 	  
 
Table 3.2 Cluster size distribution of CD24 on MCF7 cells with and without m-β-CD treated 
treatment. 
Neutravidin functionalized NPs were used in this experiment. For each cell/receptor pair, more 
than 2000 particles were evaluated from 20 randomly chosen samples. Reprinted with permission 
from (Yu et al. Anal Chem 2013 85 (3), pp. 120-1294). Copyright (2013) American Chemical 
Society. 
 
While >91% of the NP immunolabels are monomeric, for both MCF7/CD24 and 
MCF7/CD44, we found a significant degree of NP clustering. Furthermore, the SEM data 
confirms a higher degree of clustering for CD24 than for CD44. In the case of 
MCF7/CD24, 64% of the NPs are organized into clusters, and 22% formed clusters larger 
than pentamers. In contrast, for MCF7/CD44, 57% of the NPs are still monomers, and 
only 5% form clusters larger than pentamers. The quantitative SEM analysis reproduces 
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the trends form our spectral analysis; the cell surface induces a patterning of NP 
immunolabels through heterogeneous distribution of both biomarkers, but CD24 is more 
strongly clustered than CD44. 
One possible explanation for the observed differences in clustering between CD24 and 
CD44 is the preferential enrichment of CD24 in confined membrane domains, such as 
lipid rafts. We hypothesized that, if lipid rafts play an essential role in structuring cell 
surface CD24, then a lipid raft disruption, for instance, through methyl-β-cyclodextrin 
(m-β-CD), should remove the preferential NP clustering(Ohtani, Irie et al. 1989).  
To test this hypothesis, we compared the spectral distributions of NP labels targeted at 
MCF7/CD24 before and after m-β-CD treatment. Different from the previous 
experiments, we used Neutravidin instead of anti biotin antibody functionalized NPs for 
labeling CD24 under otherwise identical conditions. We changed to Neutravidin in these 
experiments since it provided comparable labeling results at much lower cost than the 
antibodies. We recorded spectra of ∼400 individual scatterers for each condition 
(with/without m-β-CD) from randomly chosen flat peripheral membrane areas in 2 
independent experiments.  
The distribution of the peak wavelength λres is shown in Figure 3.10 b. The λres 
distribution for the cholesterol depleted cells is significantly (p < 0.001) blue-shifted 
when compared with the untreated cells. The average resonance wavelengths for CD24 
on MCF7 and cholesterol depleted MCF7 cells are 557.8 ± 7.0 and 551.2 ± 5.8, 
respectively. While the cell surface expression levels remained unchanged before and 
after m-β-CD treatment through flow cytometry (data not shown), the cluster size 
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distributions, obtained from SEM analysis (Figure 3.12b), confirmed that cholesterol 
extraction through m-β-CD leads to a decrease in NP clustering. The observed 
differences in the clustering of CD24 bound NPs (at constant CD24 cell surface 
concentration) prove a substantial spatial reorganization of CD24 due to cholesterol 
sequestration. Our findings confirm the hypothesis that the observed clustering arises 
from a preferential enrichment of CD24 in lipid rafts. 
 
3.4 Conclusion 
In conclusion, we demonstrated that Au NP immunolabels facilitate an optical 
quantification of the relative expression and large-scale association levels of CD24 and 
CD44. A systematic analysis of the spectral responses of NP immunolabels selectively 
targeted at CD24 and CD44 in MCF7 cells revealed a higher degree of clustering for 
CD24 than for CD44. After cholesterol sequestration, the CD24 spectral response was 
comparable to that of CD44, confirming that CD24 clustering is caused by a preferential 
recruitment of CD24 into cholesterol enriched membrane domains.  
Since the recruitment of CD24 in lipid rafts is anticipated to impact its biological function 
in cell adhesion and cell signaling through a local concentration effect, the ability to 
quantify both concentration and lateral spatial heterogeneity provides a more complete 
description of its surface presentation than is available through conventional (i.e., 
expression-level based) approaches. The plasmon coupling based characterization of 
individual NP immunolabel clusters introduced herein facilitates the correlation of cell 
behavior and protein spatial organization and provides, therefore, opportunities for 
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improving the reliability of CD24 and CD44 as biomarkers for cancer stem cell detection 
and other applications. 
The capability of AuNPs as bright optical probes to obtain high spatial resolution with 
simple setups is confirmed in this experiment. AuNPs are not only non-blinking, non-
bleaching, enabling long-lasting high resolution imaging, but also easy to functionalize 
with interested targets. Utilizing AuNPs for building block of artificial virus 
nanoparticles is a promising design for virus imaging with good resolution and tracking 
opportunity. 
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CHAPTER 4 PLASMONIC ARTIFICIAL VIRUS NANOPARTICLE SYSTEM 
TARGETING ON HIV-1 TRANS-INFECTION 
4.1 Design of novel plasmonic artificial virus nano-particle system 
As mentioned in Chapter 1, HIV-1 viral surface plays a crucial role in establishing 
successful infection since it facilitates the binding of virus particles to the host cell and 
the subsequent initiation of an uptake program that results in the delivery of the viral 
genetic content to the intracellular virus replication machinery. Many of these 
interactions are facilitated by specific virus-encoded proteins, such as gp120, in the case 
of productive (or cis) HIV-1 infection of CD4+ T cells and macrophages.  
There is, however, a growing body of evidence that some infection mechanisms also 
depend critically on the composition of the viral lipidome (Hatch, Archer et al. 2009, 
Puryear and Gummuluru 2013). In particular, our previous data have shown the host 
derived GSL GM3 or GM1 incorporated in the virion play a central role for HIV-1 
capture by mDCs. It has also been reported that type 1 interferon-inducible Siglec1, 
CD169, has been identified as the corresponding receptor that recognizes GM3 present in 
the membrane of HIV-1 particles. (Izquierdo-Useros, Lorizate et al. 2012, Puryear, Yu et 
al. 2012) Furthermore, virus particles captured by CD169 in a GM3-dependent manner 
are sequestered in non-lysosomal compartments, and on initiation of DC–T cell contacts 
transferred to the DC–T cell synaptic junction, termed ‘virological synapse’. (Garcia, 
Pion et al. 2005, Felts, Narayan et al. 2010) 
Since the cytoplasmic tail of CD169 lack any known endocytic motifs, many details of 
the mechanisms underlying CD169-mediated HIV-1 uptake and subsequent trafficking to 
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DC–T cell virological synapses remain currently unclear. The latter is—at least in part—
due to experimental complications associated with a systematic investigation of the role 
of individual host-encoded viral surface functionalities in trans-infection.  
One particular challenge is that the compositional complexity of both cellular and viral 
surfaces gives rise to a multitude of potential interactions that can be both physical and 
chemical in nature and which are difficult to decouple in conventional virus models. A 
second complication is that mechanistic information about the cellular machinery 
orchestrating the virus trafficking is best obtained by single virus trafficking. This 
approach requires, however, bright labels that facilitate an optical tracking with high-
temporal resolution, ideally without limitation in maximum observation time. 
With the above-described performance of liposomes and AuNPs, a novel plasmonic 
artificial virus nano-particle system is thus inspired and designed to accommodate for 
HIV-1 glycoprotein free structure to investigate HIV-1 lipid dependent trans-infection 
pathway. 
HIV-1 particle assembly and budding can occur on expression of Gag alone in the 
absence of other viral proteins in host cells. The mature virus particle has a typical size 
between 120–150nm(Gentile, Adrian et al. 1994, Briggs, Wilk et al. 2003), contains 
~2,500 Gag molecules and is wrapped in a lipid bilayer that the virus acquires from the 
plasma membrane during budding from the host cell(Ganser-Pornillos, Yeager et al. 2008, 
Ganser-Pornillos, Yeager et al. 2012). The Gag polyprotein is proteolytically cleaved into 
six structural proteins, matrix (MA), nucleocapsid, capsid, p6 and two spacer proteins, 
SP1 and SP2 during the virus maturation step.  
47	  	  
	  
Schematic illustrations of the mature virus structure containing the MA protein-enclosed 
capsid shell with the nucleocapsid-coated viral RNA and the AVN models to mimic it are 
shown in Figure 4.1 a, b respectively.  
 
Figure 4.1 Design of plasmonic artificial virus nanoparticles 
Scheme of HIV-1 structure. HIV-1 is composed of a host-derived lipid bilayer membrane 
wrapped around a protein MA core that contains the viral RNA. Major lipid components of the 
viral membrane are described in Table 4.1. The viral membrane contains additional lipids, 
including GM3, albeit with significantly lower concentration. Another membrane component is 
the virus-encoded glycoprotein gp120. (b) Scheme of minimalistic artificial model systems, 
AVN1 (left) and AVN2 (right). Both AVNs are assembled from 80 nm Au NP cores and 
comprise a self-assembled lipid membrane. AVN1 contains a lipid bilayer, whereas AVN2 
contains a lipid monolayer anchored in a self-assembled octadecanethiol layer. The thiol 
covalently attaches to the NP surface. Reprinted with permission from Yu X. et al. Nat Commun. 
5:4136 (2014), Copyright (2014) Nature Publishing Group. 	  
Our AVN design is based on a self-assembled lipid layer around an 80nm diameter noble 
metal NP that serves as an analogue of the lipid enclosed core formed by association of 
basic amino-acid residues in MA with the inner leaflet of the phosphatidylinositol 4,5-
bisphosphate [PI(4,5)P2]-enriched lipid bilayer. The lipid layer emulates the virus 
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membrane but is entirely free of proteins and can be engineered with a defined lipid 
composition, ligand density and controllable surface charge.  
In this work, we are particularly interested in GM3-containing AVNs for a selective 
investigation of GM3 interactions with CD169 under well-defined conditions in the 
absence of potential interferents. HIV-1 preferentially buds from lipid rafts so that the 
host derived viral membrane is enriched in lipids with saturated fatty acids, 
glycosphingolipids, and cholesterol.  
We simplified the membrane composition for the AVNs and used a limited number of 
lipids of comparable size that provide similar physicochemical properties as the virus 
membrane. The compositions of the viral membrane and of the AVN membranes used in 
this work are summarized in Table 4.1.  
We chose DPPC containing two hydrophobic fatty acid chains and cholesterol as main 
components of the investigated membranes and integrated small quantities of PS to 
provide a negative surface charge comparable to that on HIV-1 particles. In addition, 
TopFluor-labelled cholesterol molecules were incorporated into the membrane to monitor 
AVN formation via fluorescence microscopy. Either 3 mol% GM3 or 
Galactosylceramide (Gal-Cer) was added to test the role of these lipids for binding 
CD169. We included Gal-Cer as control in our studies since it is chemically similar to 
GM3 but does not contain any sialic acid residues and, thus, was shown previously to not 
bind CD169. 
We chose gold (Au) as core material since it provides the assembled AVNs with 
mechanical stiffness and, at the same time, allows high contrast optical imaging in optical, 
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electron, and x-ray microscopy. The optical response of spherical Au nanoparticles (Au 
NPs) is dominated by localized surface plasmon resonances (LSPR) in the visible range 
of the electromagnetic spectrum. A resonant excitation of the LSPR in an 80nm AuNP is 
associated with a scattering cross-sections of approximately 2.3 x 10-10 cm-2. This huge 
elastic scattering efficiency, which is orders of magnitude larger than conventional 
fluorescence cross-sections, facilitates single particle detection entirely free from blinking 
or bleaching in conventional darkfield microscopy as validated in Chapter 3. Their 
unique photophysical stability together with their programmable surface properties make 
Au NPs the core of choice for AVNs in optical studies. 
 
 HIV-1 AVN/Blank AVN/Gal-Cer AVN/GM3 
PC 8.80% N/A N/A N/A 
SM and 
DHSM 18.4% N/A N/A N/A 
PE and pl-PE 19.2% N/A N/A N/A 
DPPC N/A 54% 51% 51% 
Cholesterol 45.1% 45% 45% 45% 
Topfluor 
cholesterol N/A 0.1% 0.1% 0.1% 
PS 8.4% 1% 1% 1% 
GM3 ~1.6% N/A N/A 3% 
Gal-Cer N/A N/A 3% N/A 
 
Table 4.1 Lipid composition of HIV-1 envelope membrane and AVNs. 
Reprinted with permission from Yu X. et al. Nat Commun. 5:4136 (2014), Copyright (2014) 
Nature Publishing Group. 
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4.2 Synthesis and characterization of AVNs 
Different experimental strategies have been developed for creating lipid layers around NP 
cores with different sizes. For the relatively large NPs of our AVN design, two strategies 
in particular are promising.  
Figure 4.2 shows the 2 strategies. Strategy 1 (S1) is based on a lipid encapsulation 
approach that traps Au NPs within uni-lamellar vesicles. Strategy 2 (S2) incorporates the 
lipids with their hydrophobic tail into an octadecanethiol brush assembled on the surface 
of Au NPs. While S1 leads to a complete bilayer membrane, S2 embeds a single layer of 
lipids into a self-assembled monolayer of octadecanethiols through their hydrophobic 
lipid tails. (Yang and Murphy 2012). 
In detail, A volume of 1 ml 1.11010 particles ml-1 colloidal Au NPs with a nominal 
diameter of 80nm (Ted Pella) were incubated with 5 ml of 10mM polyethylene glycol 
thiol propionic acid (acid–PEG) overnight, followed by three cycles of washing through 
centrifugation (600g, 10min) and resuspension in double distilled (ddi) water to remove 
excess acid–PEG. The functionalized Au NPs were resuspended into 1ml of 10mM NaCl, 
pH=7. Simultaneously, a total amount of 1 mmol of lipid mixture (Avanti Polar Lipids, 
Alabaster, AL) (major components are dipalmitoylphosphatidylcholine, cholesterol and 
phosphatidylserine, GM3 or Gal-Cer; details in Table 1) was dissolved in 100 ml 
chloroform in a clean 25 ml round-bottom flask. The flask containing the lipid mixture 
was then sonicated briefly for 5 s with a bath sonicator (Branson 5510), followed by 
rotary evaporation for 15 min. A uniformly thin lipid dry layer formed on the bottom of 
the flask, which was further dried under vacuum overnight. The above acid–PEG-
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functionalized Au NPs solution was injected into the flask through a disposable syringe 
to rehydrate the lipid film in the presence of Au NPs at 50℃ for 1 h. Subsequently, 30-
min sonication was applied to agitate the suspension and maximize lipid hydration. 
Immediately after sonication, the lipid–Au NP mixture was transferred into a cryo-vial 
under Ar protection, and underwent three freeze–thaw cycles in liquid nitrogen and 50℃ 
water. After another sonication step of 30 min, the solution was extruded through a 
200nm pore size polystyrene membrane with a mini extruder set (Avanti Polar Lipids). 
AVNs were then purified from free liposomes through three cycles of centrifugation (600 
g, 10min), and resuspended in 100 ml per 10mM NaCl for further use.  
Strategy 2 is described as follows: 
A thin dry layer of lipid mixture was prepared following the procedures described for 
AVN1. A volume of 1ml of 20mM HEPES buffer (pH=7.2) was then added, forming a 
cloudy solution after vigorous agitation. The mixture was then sonicated for 30 min in ice 
bath until the solution became clear. This liposome solution was then stored in 4 ℃ for 
further use. A volume of 1ml of 100 nm colloidal Au NP solution (1.1x1010 particles ml-1) 
was pelleted via centrifugation at 600 g for 10 min. A volume of 0.5 ml of the prepared 
liposome solution was added to the Au pellet, and the volume was increased to 1ml with 
20mM HEPES buffer. A volume of 200 ml of 0.01 mg ml-1 1-octadecanethiol solution in 
ethanol was then added dropwise to the mixture. The mixed solution was agitated 
overnight on a rotator. After that, the AVNs were washed three times through 
centrifugation (600 g, 10min) and resuspended in ddi water. Finally, the AVN pellet was 
resuspended in 100 ml 20mM HEPES buffer and ready to use. 
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Both S1 and S2, achieve a presentation of GM3 on the AVN surface with the sialic acid 
containing sugar head group pointing into the solution. We therefore refer to the artificial 
virus NPs obtained through these two strategies asAVN1 and AVN2, respectively. 
Although S2 is synthetically simpler and more efficient than S1, lipid mobility and 
density obtained via S2 are anticipated to differ from those of the native bilayer 
membrane of enveloped virus particles. A priori it was, therefore, unclear if AVN2 could 
successfully mimic virus-like behavior and we consequently pursued and evaluated both 
strategies. 
 
 
 
Figure 4.2 Strategies for AVN fabrication. 
Schematic overview of fabrication strategies S1 (top) for AVN1 and S2 (bottom) for AVN2. The 
encapsulation strategy S1 traps Au NPs in liposomes formed in situ, whereas in S2 pre-formed 
liposomes act as lipid reservoir for the assembly of lipid membranes around octadecanethiol-
coated Au NPs in a one-pot process. Lipo, Liposome. Reprinted with permission from Yu X. et al. 
Nat Commun. 5:4136 (2014), Copyright (2014) Nature Publishing Group. 	  
Centrifugation purified AVNs are then carefully characterized. We firstly measured 
AVNs sizes by measuring their hydrodynamic diameters and zeta potentials (ZP) (Figure 
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4.3 a,b). The hydrodynamic radius, reported as the peak in the size distribution obtained 
through dynamic light scattering, for GM3-containing AVN1 is rhyd(AVN1) = 77.8±5.3 
nm (s.d.) compared with rhyd(AVN2) = 50.7±3.0 nm (s.d.) for GM3-containing AVN2. 
The observed difference in rhyd between AVN1 and AVN2 is too large to be accounted for 
only by differences in the membrane shell. Instead, the measured size difference indicates 
some self-association of the 80nm Au NPs in the case of AVN1.  
 
 
 
Figure 4.3 Characterization of AVNs. 
ZP and average hydrodynamic diameter of (a) AVN1 and (b) AVN2 without glycosphingolipids 
(blank) or containing 3% Gal-Cer, or 3% GM3. The presented data were obtained from three 
independent experiments. Darkfield image, fluorescence image, overlay and colocalization 
statistics (clockwise top left to bottom right) for (c) AVN1 and (d) AVN2. A quantity of 1,000 
particles were evaluated for each colocalization statistics. Representative TEM image of (e) 
AVN1 and (f) AVN2. The insets in (e) and (f) contain magnified views of selected AVNs, which 
show a distinct corona formed by the self-assembled lipids around the NPs. Scale bars, 10 mm in 
(c) and (d) and 20nm in (e) and (f). Reprinted with permission from Yu X. et al. Nat Commun. 
5:4136 (2014), Copyright (2014) Nature Publishing Group. 	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Consistent with an increased level of NP clustering, the ultraviolet–visible spectra (Figure 
4.4) confirm a red-shift of the ensemble averaged plasmon resonance wavelength of ~8 
nm for AVN1 when compared with AVN2.  
 
 
Figure 4.4 UV-VIS spectra of AVN1 (left) and AVN2 (right). 
Blank, Gal-Cer, and GM3 particles of type AVN1 have peak resonance wavelengths of 561 nm, 
which compares with 550 nm for citrate stabilized 80 nm Au NPs. The peak wavelengths for 
blank, Gal-Cer, and GM3 functionalized particles of type AVN2 are 553nm. Reprinted with 
permission from Yu X. et al. Nat Commun. 5:4136 (2014), Copyright (2014) Nature Publishing 
Group. 
 
Both of the AVNs have zeta potentials between -20 and approximately -30 mV, which is 
close to the published value for HIV-1 particles of -20mV under identical experimental 
conditions. Due to their resonant interaction with the incident light, the Au NPs used in 
this work are extraordinarily bright and have a characteristic green-orange color. 
Liposomes and other organic contaminations with comparable sizes, in contrast, are dim 
(Figure 4.5) or appear as broad band scatterers, which makes them easily discernible 
from metal NPs.  
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Figure 4.5 Scattering intensity comparison between AVN with liposomes. 
Box plot of the intensity distribution of AVN2 and liposomes with comparable sizes under the 
same darkfield image setup and recording conditions. AVNs are at least 10 fold brighter than 
liposomes. Reprinted with permission from Yu X. et al. Nat Commun. 5:4136 (2014), Copyright 
(2014) Nature Publishing Group. 
 
Correlated darkfield/fluorescence microscopy is, therefore, an appropriate method for 
validating successful lipid wrapping around the NPs. Figure 4.3 c, d show darkfield and 
fluorescence images of surface-immobilized AVN1 and AVN2 for representative 
preparations. Consistent with a successful formation of AVNs that contain both lipid and 
noble metal NP components, the images show >90% colocalization of fluorescence and 
darkfield signals for all AVN preparations. The exact colocalization statistics for ~1,000 
particles of each type are summarized in the insets. Control experiments performed with 
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pegylated Au NPs incubated with TopFluor cholesterol in the absence of lipids did not 
yield any measurable fluorescence signal (Figure 4.6).  
 
 
 
 
Figure 4.6 Fluorescent background of AuNPs. 
Darkfield image (a) and fluorescence image (b) of 80nm AuNP after overnight incubation with 
octadecanethiol-ethanol solution together with topfluor-cholesterol dye, but no lipids. After 
surface immobilization and washing, no signal is observed from the topfluor dye channel. This 
finding proves that there is no significant non-specific adsorption of the dye molecule to the 
octadecanethiol coated particle surface in the absence of an intact membrane structure. Scale bar 
= 10µm. Reprinted with permission from Yu X. et al. Nat Commun. 5:4136 (2014), Copyright 
(2014) Nature Publishing Group. 
 
High-resolution TEM images of AVN1 and AVN2 (Figure 4.3 e,f) show a distinct corona 
around the NPs, which is an additional proof of successful membrane assembly around 
the NPs. For AVN2, the corona is 4-5nm thin. Together with the small difference 
between rhyd(AVN2) and the hydrodynamic radius of the citrate stabilized Au NPs 
(rhyd=49.0±1.2nm (s.d.)), the thin corona indicates the addition of a single-lipid layer to 
the octadecanethiol-functionalized NPs in the AVN2 assembly process. Consistent with 
the larger rhyd and relative spectral red-shift for AVN1 when compared with AVN2, the 
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TEM images show mostly small clusters for AVN1, whereas for AVN2, individual Au 
NPs are predominantly observed. Although AVN1 preparations show some partial NP 
self-association, the average sizes of both AVN1 and AVN2 overlap with the natural size 
distribution of a HIV-1 virion. We conclude that based on the physical parameters of size, 
shape and surface charge, both S1 and S2 represent viable synthetic strategies for AVNs.  
We also tested the mechanical stiffness of individual VLPs and AVN2 particles through 
atomic force microscopy nanoindentation measurements (Wampler and Ivanisevic 2009) 
and found that AVN particles are stiffer than VLPs or liposomes. These findings are 
consistent with previous nanoindentation studies that reported a Young’s modulus in the 
few GPa range and above for biomolecule loaded Au NPs and Young’s moduli of ~950 
MPa or ~440 MPafor immature and mature HIV virions, respectively. Liposomes are 
softer than both AVNs and virus particles; egg-PC cholesterol (1:1) liposomes, for 
instance, have a Young’s modulus of ~13 MPa. (Liang, Mao et al. 2004) 
 
4.3 Targeting on HIV-1 trans-infection with AVNs 
4.3.1 Specific interaction between GM3 with CD169 
VLPs are currently the model systems of choice for investigating the viral glycoprotein-
independent capture of HIV-1 particles, whose behavior defines logical benchmarks for 
the evaluation of our reverse engineering strategy.  
HIV Gag-eGFP VLPs were generated as previously described, by transient transfection 
(calcium phosphate mediated) of HEK293T cells with the pGag–eGFP plasmid 
expressing codon-optimized Gag–eGFP fusion protein. VLPs were collected 2 days post 
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transfection, purified from cell debris by filtering through 450nm pore size filters, and 
stored at -80 ºC prior to use. 
In a first round of calibration experiments, we evaluated the binding specificity of VLPs 
in HeLa cells transduced to constitutively express CD169 (HeLa/CD169). Cells were 
incubated for 10 min with 1 x 1010ml-1VLPs in Dulbecco's modified Eagle medium 
(DMEM), washed and transferred to the fluorescence microscope for an optical 
inspection of the binding. We found that VLPs bound efficiently to HeLa/CD169 (Figure 
4.7a) but not to CD169-negative parental HeLa cells (Figure 4.7b). This selective binding 
confirms that VLP binding is CD169 specific. Previous studies by Puryear et al. and 
Izquierdo-Useros et al. have demonstrated that GM3-mediated interactions of VLPs and 
infectious HIV-1 particles with CD169 on mature DCs induced a polarized virus 
distribution that resulted in an accumulation of the particles in non-lysosomal focal spots 
with preferential localization at the cell periphery. This characteristic spatial distribution 
was typically observed within 1-2 h after virus binding with the exact time depending on 
the particle concentration. Interestingly, we observed a similar clustering of VLPs in 
HeLa/CD169 only when the cells were cultured for additional time after exposure to the 
VLPs. While the VLPs are initially randomly distributed across the surface of 
HeLa/CD169 cells (Figure 4.7a), they experience a spatial redistribution as a function of 
time. In ~1/3 of the cells, this redistribution culminates after 20 h in a strong local 
enrichment of VLPs in spatially confined spots. In good agreement with previous 
observations in DCs, the locations of VLP enrichment do not co-stain with LysoTracker, 
which is a marker for acidified intracellular compartments, and the VLP enriched spots 
59	  	  
	  
are often located at the cell periphery (Figure 4.7 c, d). We augmented the VLP tracking 
with simultaneous spatial mapping of the CD169-mCherry fusion protein and observed 
strong enrichment of CD169-mCherry at the site of VLP clustering (Figure 4.7 e-g), 
consistent with a role of CD169 as the receptor for HIV Gag VLPs. 
 
Figure 4.7 Spatial redistribution of HIV Gag–eGFP VLPs after binding to HeLa/CD169 
cells. 
The VLPs selectively bind to (a) HeLa/CD169 cells but not to (b) parental HeLa cells after 10 
min of incubation. (c,d) Twenty hours after binding to HeLa/CD169, the initially randomly 
distributed VLPs are enriched in peripheral compartments that do not co-stain with lysosome 
tracker. Fluorescence images of (e) CD169–mCherry, (f) VLP and (g) overlay 20 h after initial 
incubation with HIV Gag–eGFP VLPs. The fluorescence data show a strong optical 
colocalization of CD169 and VLPs. The VLP segregation was confirmed in two independent 
imaging experiments. Scale bars, 5 mm. Reprinted with permission from Yu X. et al. Nat 
Commun. 5:4136 (2014), Copyright (2014) Nature Publishing Group. 	  
We then tested if nanoconjugated GM3 is a ligand for CD169 by quantifying the binding 
efficacies of GM3 and Gal-Cer-containing AVNs and of blank controls. HeLa and 
HeLa/CD169 cells were incubated with 5x108ml-1AVNs in DMEM for 10 min, washed to 
remove unbound particles and inspected via darkfield microscopy. Interestingly, only 
GM3-containing AVN1 (Figure 4.8a) and AVN2 (Figure 4.8b) but not Gal-Cer-
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containing AVN1 (Figure 4.8c) or AVN2 (Figure 4.8d) bind to HeLa/CD169 cells. GSL-
free blank AVN1 (Figure 4.8e) or AVN2 (Figure 4.8f) also did not bind to HeLa/CD169 
cells. 	  
	  
 
Figure 4.8 Binding specificity of AVNs. 
(a) Darkfield image of HeLa/CD169 cells after 10 min of incubation with AVN1 particles 
containing 3% GM3. AVN1 binds efficiently to HeLa/CD169. (b) AVN2 particles containing 3% 
GM3 also show efficient binding to HeLa/CD169 under otherwise identical conditions. In 
contrast, (c) AVN1 or (d) AVN2 particles with 3% Gal-Cer show no binding to HeLa/CD169 
cells. Similarly, the binding of (e) AVN1 blanks or (f) AVN2 blanks (no GM3 or Gal-Cer) to 
HeLa/CD169 is negligible. (g) Relative intensity distribution on the red (R), green (G) and blue 
(B) color channels of a digital camera for an AVN-bound cell surface (see inset) and (h) for 
control cell surface void of AVNs. Scale bars, 10 μm. GM3 binding specificity studies were 
independently repeated >3 times. Reprinted with permission from Yu X. et al. Nat Commun. 
5:4136 (2014), Copyright (2014) Nature Publishing Group. 	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In additional control experiments, we verified that GM3-containing AVNs do not bind to 
HeLa cells (Figure 4.9). Together, these observations confirm that GM3-functionalized 
AVNs bind specifically to CD169. We included a comparison of the spectral content of 
AVNs and cellular background by analyzing the relative intensity distribution on the red 
(R), green (G) and blue (B) color channels of the digital camera used to acquire the cell 
images. While the intensity of the cellular background is equally distributed across the R, 
G, B channels, the relative contributions from the R and G channels are locally increased 
in areas containing AVNs. We conclude that, due to their spectral characteristics and 
their high intensity (see insets), AVNs built around an 80nm Au core can be 
differentiated with high fidelity even from grainy background in the investigated single-
cell layer. 
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Figure 4.9 Control images. 
Dark-field (a) and fluorescent image (b) of HeLa/CD169 cells after staining with Alexa-647 
conjugated CD169 antibody. Approximately 60% of the cells were stained by the antibody, 
indicative of significant expression of CD169 receptor on the cell surface. In contrast, the 
darkfield image (c) and fluorescent image (d) of CD169-null HeLa cells shows no detectable 
expression of CD169 receptors after an identical staining procedure. The darkfield image (e) of 
GM3 AVN2 treated HeLa cells shows no binding, which further underlines the need for CD169 
expression to achieve GM3 specific binding. Scale bars = 10µm. Reprinted with permission from 
Yu X. et al. Nat Commun. 5:4136 (2014), Copyright (2014) Nature Publishing Group. 	  
To further characterize the GM3 AVNs binding with mDCs, we varied the AVN input to 
mDCs, and tested the binding level. 
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Here we only tested with AVN2 since AVN2 has a generally simpler fabrication process, 
and more stable for storage, and also contain only one individual particle as similar with 
the viral capsid. 
Primary monocyte-derived DCs were differentiated from CD14+ peripheral blood 
monocytes, and matured with lipopolysaccharides (10 ng ml-1) 2 days before experiments. 
1x107, 1X108, 1X109 AVNs containing no GM3 or Gal Cer, 3% Gal Cer, or 3% GM3, 
were added to 3x105 mature DCs respectively, and incubated in serum free growth 
medium (Roswell Park Memorial Institute Medium, RPMI-1640) at 37˚C 5% CO2 for 
5min. Free unbound AVNs were then removed by centrifugation at 270 xg for 5min. The 
cells were then fixed with 4% paraformaldehyde, and dialyzed through 1um-pore 
polystyrene membrane overnight. The cells were then concentrated by centrifugation, and 
counted for further use. 
After the incubation of GM3-AVNs with DCs, as well as GalCer-AVNs and blank 
controls with mDCs for 5 min at 37˚C at three different AVN/mDC ratios (1x107/3x105; 
1x108/3x105; 1x109/3x105), we further determined AVN binding quantitatively by 
inductively coupled mass spectroscopy (ICP-MS, Figure 4.10). The mDCs were also 
visually inspected in the dark-field microscope.  
In detail, cell samples were digested by dissolving in Aqua Regia (made by ultrapure 
hydrochloric and nitric acids) and letting heat and dry at 70˚C overnight in 6-well dishes. 
The precipitates of every sample were, then, dissolved in 4 ml 2% ultrapure HCl. The 
concentration of gold in the samples was then measured by a Thermo (VG) PlasmaQuad 
(PQ) ExCell Inductively Coupled Plasma Mass Spectrometer (ICP-MS) connected to a 
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CETAC ASX-520HS autosampler for high speed unattended measurement of multiple 
samples. The background of the gold trace in the Milli-Q water, 2% HCl and Aqua Regia 
was measured and subtracted from the other samples. In addition, standard samples with 
different gold concentrations (0.1 to 10 ppb) were prepared by serial dilutions in 2% HCl 
and used to produce the calibration curve, and a specific concentration was periodically 
measured between other samples to monitor and correct on the drift of the detection in 
each run of the measurements. The number of ICPs of gold with atomic mass 197 was 
used as the measure of gold concentration in each sample, and the measurement was 
repeated 20 times and the average value and standard deviation (always less than 2%) 
were computed. 5% HCl was used to wash the system for 3 minutes before every new 
measurement. 
For the AVN/mDC ratios of 1x109/3x105 and 1x108/3x105 , the GM3-AVNs show a four 
to five fold higher binding than GalCer-AVNs or blank controls (Figure 4.10). For the 
1x107/3x105 ratio the gold concentration was below the detection limit of ICP-MS under 
our experimental conditions but the optical inspection still revealed appreciable binding 
of GM3-AVNs but not of GalCer-AVNs or blank controls as shown in Figure 4.11. 
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Figure 4.10 Specificity binding of GM3-AVNs by mDCs via ICP-MS. 
 
 
 
Figure 4.11 Specificity binding of GM3-AVNs by dark-field microscopy. 
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In conclusion, the GM3 AVNs bind with CD169 presenting cells specifically with high 
efficiency within 10min. This is the prerequisite to use AVNs as potential tools to target 
the behaviors after the initial particle capture.  
4.3.2 HIV-1-like re-distribution of AVNs upon capture by CD169 presenting cells 
In the next step, we verified whether GM3-containing AVNs reproduce the observed 
VLP behavior. We took advantage of the large optical cross-sections of GM3-
functionalized AVNs to determine their spatial distribution in HeLa/CD169 cells 20 h 
after initial AVN binding. These experiments revealed a characteristic spatial 
redistribution of the AVNs from an initial random distribution to a preferential spatial 
enrichment in discrete spots at the cell periphery. The presentative darkfield images of 
GM3-containing AVN1-treated (Figure 4.12 a, b) and AVN2-treated (Figure 4.12 c, d) 
HeLa/CD169 cells acquired 20 h after AVN exposure illustrate the formation of distinct 
NP clusters at the cell periphery. In the case of AVN2, we also performed fluorescence 
staining experiments to image the acidified membrane compartments and the cell nuclei 
(Figure 4.12 e, f). 
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Figure 4.12 GM3-containing AVNs are sequestered in peripheral cellular regions in 
HeLa/CD169 cells. 
(a–d) Darkfield images of HeLa/CD169 cells 20 h after an initial 10 min exposure to GM3-
containing (a,b) AVN1 or (c,d) AVN2. (e,f) Corresponding fluorescence images of HeLa/CD169 
with GM3-containing AVN2 after nucleus (blue) and LysoTracker (red) staining. The AVNs 
show an enrichment in regions that do not co-stain with the LysoTracker.(g) Darkfield, (h) 
CD169–mCherry fluorescent image and (i) overlay of GM3–AVN2 on HeLa/CD169–mCherry 
cells 20 h after incubation, which confirms increased CD169 concentrations at locations of AVN2 
enrichment. The images in (a–i) show representative cells from five independent experiments.(j–
l) Overlaid darkfield (green) and fluorescence LysoTracker images (red) of HeLa/CD169 cells 
after (j) 4 h of incubation with epidermal growth factor functionalized 80 nm Au NPs, (k) 20 h 
after incubation with pegylated 80nm Au NPs, or (l) 20 h after 10 min incubation with 
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fluorescently labelledGM3–liposomes. Scale bars, 10 µm. Reprinted with permission from Yu X. 
et al. Nat Commun. 5:4136 (2014), Copyright (2014) Nature Publishing Group. 	  
The correlated darkfield/fluorescence images reveal that the locations of high AVN 
concentration do not colocalize with LysoTracker. The preferential localization of AVN 
clusters at the HeLa/CD169 cell periphery in LysoTracker-negative compartments 
excludes conventional lysosomal compartments as origin of the large-scale AVN 
clustering, similar to the localization pattern observed with HIV Gag-eGFP VLPs.  
As in the case of the VLPs, we observed this phenotype in ~1/3 of all investigated cells. 
We attribute the variability in the cellular response to AVNs and VLPs to the intrinsic 
heterogeneity of immortalized cancer cell lines, as well as to variations in the CD169 
expression level on the single-cell level. The observation of similar spatio temporal 
distributions for both AVN1 and AVN2 implies that the intact lipid bilayer membrane of 
AVN1 is not required to trigger GM3–CD169-mediated cellular processes, but that the 
presentation of GM3 in a single leaflet tethered to a solid core, as is the case for AVN2, is 
sufficient to successfully reproduce HIV Gag VLP behavior in HeLa/CD169 cells. 
We correlated AVN clustering with the spatial CD169 distribution through combination 
of darkfield and fluorescence microscopy in HeLa cells expressing CD169-mCherry 
fusion protein. Analogous to the colocalization of CD169 with HIV Gag-eGFP VLPs 
(Figure 4.7 e-g), the overlay of darkfield and fluorescence images in Figure 4.12 g-i 
reveals an enrichment of CD169 at the sites of AVN clustering. The co-clustering of 
AVNs and CD169 20 h after AVN binding implies that GM3 remains associated with the 
NPs after binding to the cell. The demonstration of CD169-dependent binding and spatial 
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clustering of AVNs confirms a successful reproduction of the HIV Gag VLP behavior in 
HeLa/CD169.  
Since GM3 is the only ligand on the AVN surface, and because the non-specific binding 
of AVNs without GM3 is negligible, the successful reverse engineering of HIV Gag 
VLPs with AVNs provides direct experimental evidence that GM3_CD169 binding 
interactions are responsible for triggering the cellular response that culminates in the 
observed spatial sequestration of HIV Gag VLPs and AVNs. 
We also emphasize that the spatial redistribution observed forGM3-functionalized AVNs 
cannot be attributed to a general cellular response to non-degradable inorganic 
nanomaterials. The spatial sequestration of AVNs is strikingly different from what is 
typically observed for NPs that undergo conventional endocytosis. Epidermal growth 
factor functionalized NPs (Figure 4.12 j), which target the endocytic epidermal growth 
factor receptor, as well as pegylated NPs (Figure 4.12 k), are collected in perinuclear, 
acidified compartments.  
Due to the long time gap of 20 h between AVN exposure and analysis of AVN 
distribution in Figure 4.12 a–i, we can also exclude the possibility that intermediate 
endocytosis states are observed for the GM3-containing AVNs. Instead, the unique 
spatial distribution of the AVNs corroborates the hypothesis that GM3–CD169 binding 
elicits a distinct cellular response different from conventional endocytosis. Interestingly, 
this behavior was found to be specific to AVNs, while GM3-containing liposomes of 
identical composition were exclusively collected in lysosomal compartments (Figure 4.12 
l). This difference between the soft liposomes and the stiffer, metal core containing 
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AVNs indicates a role of the mechanical properties in determining the intracellular fate of 
virus particles. 
Although HeLa/CD169 cells are a useful model system to test and calibrate AVNs, it is 
unclear to what degree the observed spatial segregation of AVNs in HeLa/CD169 cells is 
relevant in DCs that mediate HIV-1 transinfection. To clarify this question, primary 
monocyte-derived DCs were matured with Escherichia coli lipo-polysaccharides and then 
incubated with AVNs. While binding of Gal-Cer or blank AVNs to mature DCs was very 
low (Figure 4.11), GM3-containing AVNs bound efficiently to mature DCs.  
 
Figure 4.13 shows darkfield and fluorescence images of mature DCs that were 
continuously incubated with GM3-containing AVN1 for 1 h under culture conditions 
similar to those for HeLa/CD169 cells. We observed that GM3–AVNs captured by 
mature DCs were redistributed and collected in tightly focused spatial locations. For 
mature DCs, 1 h of incubation with AVNs was sufficient to result in a strongly polarized 
AVN distribution with large NP clusters preferentially located at the cell periphery 
(Figure 4.13a). Darkfield and fluorescent LysoTracker co-staining experiments (Figure 
4.13 b–d) confirm that the AVN-enriched compartments in mature DCs are distinct from 
lysosomal compartments since no colocalization was observed between AVNs and 
lysosomal marker. While in HeLa/CD169 cells, multiple smaller AVN clusters are 
frequently found within a single cell, in mature DCs, we preferentially observed the 
formation of one single compartment highly enriched in AVNs. 
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Figure 4.13 Sequestration of GM3-containing AVN2 particles in mature DCs. 
(a) The color darkfield image of a representative DC after 1 h of incubation shows a distinct AVN 
cluster in a peripheral position. The overlay of (b) monochromatic darkfield and (c) LysoTracker 
images in (d) shows that AVNs are not sequestered into lysosomes. (e) Color darkfield, (f) 
monochromatic darkfield and (g) fluorescence images of DCs co-incubated with Gag–eGFP 
VLPs for 1 h. (h) The overlay of darkfield and fluorescence images confirms that areas enriched 
in AVNs and VLPs colocalize. (i) colordarkfield, (j) monochromatic darkfield and (k) 
fluorescence images of DCs incubated with AVNs and then fluorescently labelled for CD81. (l) 
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The overlay images reveal that AVN-containing compartments are associated with CD81. Scale 
bars, 5 µm. All DC experiments were independently repeated with primary cells from at least two 
donors. Reprinted with permission from Yu X. et al. Nat Commun. 5:4136 (2014), Copyright 
(2014) Nature Publishing Group. 	  
Although the data obtained with both mature DCs and HeLa/CD169 cells confirm the 
existence of a cellular process that results in a spatial coalescence of bound AVNs, 
CD169-mediated trafficking and localization of AVNs in peripheral non-lysosomal 
compartments occur with faster kinetics and is more pronounced in mature DCs. 
We correlated the spatial distributions of VLPs and AVNs in mature DCs through 
combined fluorescence and darkfield microscopy after 1 h of incubation. We found that 
the regions enriched in VLPs and AVNs show an almost perfect colocalization (Figure 
4.13 e-h), confirming that both VLPs and AVNs are sequestered into identical 
compartments. Previous studies have demonstrated that cellular compartments containing 
infectious HIV-1 particles in mature DCs are enriched in tetraspanins. We 
immunolabelled the tetraspanin CD81 and imaged its distribution through fluorescence 
microscopy. These experiments revealed an unambiguous association of CD81 with 
AVN-containing compartments (Figure 4.13 i–l).(Garcia, Pion et al. 2005) 
 
The multimodal Au core of AVNs makes it possible to investigate the peripheral 
accumulation of AVNs observed in the optical microscope via scanning electron 
microscopy (SEM) and focused ion beam (FIB) milling. SEM detects the secondary 
electrons generated on impact from a primary electron beam. Since the secondary 
electrons have a very short escape depth, SEM imaging is highly surface specific. Figure 
4.14 shows an optical darkfield (a) and correlated SEM (b) image of a representative 
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HeLa/CD169 cell 20 h after addition of AVN2. The optical image indicates a large 
number of bound AVNs and their clustering in a peripheral cell area (White Square in 
Figure 4.14a). A SEM image of the entire cell is shown in Figure 4.14 b. Before any FIB 
milling, the number of detected NPs in this area is low, and those NPs that are detected 
are located right at the cell edge where the cell is very thin (Figure 4.14 c).  
To obtain further information about the relative localization of the AVN clusters with 
regard to the cell membrane, we removed cellular material through FIB milling in the 
area under investigation. Figure 4.14 d and the magnified view show that already after the 
removal of only 10nm of cellular material, additional AVN clusters (red arrows) as well 
as individual AVNs (green arrows) become detectable in areas that did not contain NPs in 
Figure 4.14 c. Some clusters are only faintly visible, indicating that they are still mostly 
contained in the cell matrix. An additional milling of 60nm further excavates the large 
AVN clusters (Figure 4.14 e). A tilted view (52 ˚C) of the area after removal of ~90nm of 
cellular material is included in Figure 4.14f.  
When we milled even deeper, the AVNs were gradually removed and no additional 
AVNs were observed in the investigated cell section. The picture that emerges from our 
combined optical and electro microscopic characterization is that, in HeLa/CD169 cells, 
the GM3–CD169-mediated AVN sequestration at the cell periphery leads to localization 
of AVN clusters within tens of nanometres below the plasma membrane. At the very 
edge of the cell, where the cell is thinnest, the AVNs can be located directly on the cell 
surface. 
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Figure 4.14 SEM/FIB of HeLa/CD169 cells 20 h after exposure to GM3-containing AVN2. 
(a) Darkfield image of a representative cell with AVN2 clusters. (b) SEM image of the same cell 
after drying and coating with a 5nm thin Au/Pd layer. (c) Magnified SEM image of the cell 
surface in the area of interest marked with a white square in (a,b). The magnified view shows 
AVN2 particles and clusters located on the cell surface. (d) After removal of ~10nm of cellular 
material through FIB milling, more clustered (red arrow) and individual (green arrow) AVN2 
particles emerge. (e) After an additional removal of ~60 nm, the AVN2 clusters (red arrow) and 
monomers (green arrow) are all completely excavated. (f) SEM image of the area of interest 
recorded with a tilt angle of 52 ˚C after removal of another ~20nm cellular material. No 
additional AVN2 are exposed. Scale bars, 5 µm for (a,b),and 2 µm for (c,f). Reprinted with 
permission from Yu X. et al. Nat Commun. 5:4136 (2014), Copyright (2014) Nature Publishing 
Group. 	  
The observation of AVN enrichment close to the membrane in HeLa/CD169 cells 
warrants additional future studies into the spatial localization of GM3-functionalized 
AVNs in DCs, where the dynamic range of possible separations between AVNs and 
plasma membrane is much larger. Our studies also suggest that AVNs in combination 
with SEM/FIB as an invaluable tool in future studies to determine the localization of 
GM3-functionalized AVNs in DCs. 
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To further reveal the location of AVNs inside of the mDCs, we also did traditional 
fixation and sectioning of cells into 1um thick slices, and inspected under Scanning 
Electron Microscope (SEM). 
In detail, 5.6 x 106 mature DCs were incubated with 5.6 x 109 GM3-containing AVN2 for 
1 hour at 37˚C. Cells were washed twice with PBS and fixed with 4% PFA and 1% 
glutaraldehyde in 0.1 M PHEM buffer (60 mM PIPES, 25 mM HEPES, 2 mM MgCl2 and 
10 mM EGTA). Cells were further fixed with 2% osmium tetroxide, dehydrated in 
ethanol and embedded in epoxy resin as previously reported. Semi-thin sections (0.8 µm) 
of embedded cells were stained with 1% toluidine blue and inspected by light microscopy 
to verify presence of sufficient cells. Sections with thickness of approximately 1 µm) of 
cells were dried down on a glass cover slip which was attached to a SEM sample holder 
(stub) with double-sided copper tape. The samples were then coated with a layer of 
carbon (50-80 nm) in a DV-502 high vacuum evaporator (Denton Vacuum, Cherry Hill, 
NJ). A strip of PELCO Colloidal Graphite (Ted Pella, Redding, CA) connected glass 
cover slip to metal stub for grounding. 
The SEM sample was then imaged with a Zeiss Supra 55VP Field Emission Scanning 
Electron Microscope at 2-5 kV, and elementarily analyzed by Energy Dispersive X-ray 
Spectroscopy (EDAX) equipped on the SEM. 
Figure 4.15 shows one representative section of the cell slice and the enlarged area 
magnifies the AVNs of interest. It's easy to see the particles locate inside of the near-cell 
surface-pocket. The EDAX elementary analysis confirms the observed structure is 
composited by gold. 
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Figure 4.15 SEM inspection of AVN locations within mDCs. 
a. SEM of one representative cell cross-section. The squared area is enlarged by the side. 
b. EDAX elementary analysis of the bright area in the square confirms the nature of the material 
to be gold. 
 
Self-assembled biomimetic nanosystems with defined surface properties represent 
engineerable model systems for characterizing the role of specific surface functionalities 
in virus–host cell interactions. We have used this approach to validate the role of GM3 in 
the viral envelope glycoprotein-independent binding and cellular trafficking of HIV-1 via 
a reverse engineering approach. Our observations that GM3 loaded AVNs are 
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sequestered into the same compartments as VLPs and that these compartments are 
associated with tetraspanins provide experimental evidence for an imitation of virus 
particle behavior by AVNs.  
The successful mimicry of HIV-1 trafficking mechanisms in monocyte-derived DCs and 
HeLa/CD169 cells with AVNs that contain only GM3 as a potential ligand 
unambiguously confirms the hypothesis thatGM3 is the non-virus-encoded surface 
functionality that facilitates an envelope protein-independent capture of HIV-1 particles. 
Since the AVNs generated in this work share similarities with GM3-presenting exosomes, 
our findings are consistent with the Trojan exosome hypothesis that HIV has parasitized 
host intercellular vesicle trafficking pathways to enhance its dissemination. 
4.3.3 Discussion 
We implemented two types of GM3-containing AVNs, one containing a complete lipid 
bilayer membrane (AVN1) and the other containing a single-lipid layer grafted onto the 
NP surface through hydrophobic interactions (AVN2). The fact that both GM3-
functionalized AVN1 and AVN2 bind to HeLa/CD169 but not HeLa cells confirms that 
CD169 is the receptor for nanoconjugated GM3, independent of its presentation in a lipid 
monolayer or bilayer. Both types of AVNs were found to elicit a unique spatial 
sequestration in both HeLa/CD169 and mature DCs. Based on the particle distribution 
obtained by darkfield imaging, AVN clustering occurs preferentially in peripheral cell 
areas for both mature DCs and HeLa/CD169 cells.  
Combined SEM/FIB investigations in HeLa/CD169 cells substantiated this finding by 
revealing an accumulation of AVN clusters within tens of nanometres below the plasma 
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membrane. In principle, this enrichment of the AVNs in direct vicinity of the plasma 
membrane could be the result of an exocytic intracellular pathway that directs a 
significant fraction of endocytosed AVNs from multivesicular endosomes to the plasma 
membrane via exosomes, especially in immature DCs. Recent studies have, however, 
questioned, the role of the exocytic mechanisms in the peripheral sequestration of HIV in 
mature DCs and, instead, suggested capture and retention of virus in solvent accessible 
plasma membrane invaginations.  
While the localization of virus particles in solvent accessible membrane invaginations is 
considered essential for efficient inter-cell transfer of viral particles during transinfection, 
the mechanism by which CD169 traffics virus particles to these peripheral compartments 
remains unclear. Independent of the exact mechanisms underlying the collection of 
AVNs in peripheral clusters, the fact that the GM3 containing minimalistic AVNs induce 
this unique spatial distribution in HeLa/CD169 cells provides experimental evidence in 
support of the hypothesis that GM3–CD169 interactions play a key role in orchestrating 
the cellular response of DCs during HIV-1 transinfection. Interestingly, GM3–CD169 
binding can induce this cellular program despite the absence of any previously defined 
endocytotic motifs in the cytoplasmic tail of CD169. 
The dynamics of the spatial sequestration of AVNs and VLPs in HeLa/CD169 cells was 
found to be slower and the extent less significant than in mature DCs. VLP/AVN 
clustering in peripheral compartments in HeLa/CD169 cells was apparent at20 h post 
VLP/AVN exposure (Figure 4.7 c, d and 4.12 a–i). The lack of endocytotic motifs in the 
cytoplasmic tail of CD169, together with the observation that the sequestration kinetics of 
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AVNs are significantly faster in mature DCs (within 1 h; Figure 4.13) than in 
HeLa/CD169, points towards the existence of yet to be identified membrane associated 
co-factors or mechanisms that accelerate virus uptake and processing after GM3–CD169 
engagement in mature DCs. 
The fact that in HeLa/CD169 a sequestration was observed for GM3-containing AVNs 
but not for GM3-functionalized liposomes indicates that the presentation of GM3 is 
necessary but not sufficient to trigger sequestration. One striking difference between 
AVNs and liposomes of identical size and membrane composition is the difference in 
structural stiffness. Liposomes are much softer than HIV virions or metal NP containing 
AVNs. One conclusive rationalization of the differences between liposomes and AVNs is, 
therefore, that mechanical properties also influence the intracellular fate of virus particles 
and that—unlike the AVNs—the liposomes are too soft to induce the sequestration 
observed for the virus.  
The observed differences in the spatio temporal distribution of AVNs and liposomes 
argue in favor of AVNs as the more realistic model system for validating the potential 
role of specific membrane functionalities in the HIV-1 transinfection mechanism. In 
addition, AVNs have the advantage that they are multimodal and can be imaged with 
high contrast in both optical and electron microscopy. 
The experimental validation that GM3-functionalized AVN successfully mimic viral 
behavior has important implications beyond elucidating fundamental mechanistic details 
of the GM3-CD169-mediated transfection pathway. A selective capture of GM3–AVNs 
by CD169 paves the path to new delivery strategies that can selectively deliver drugs and 
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vaccines to CD169-expressing DCs and macrophages in vivo, which are key components 
of the immune system. Furthermore, our experimental findings show vividly that in 
contrast to endocytosis and targeting to lysosomal compartments (Izquierdo-Useros, 
Naranjo-Gomez et al. 2010), alternative cellular uptake and trafficking mechanisms can 
be targeted by smart NPs with rationally designed lipid membrane surfaces.  
The successful mimicry of HIV-1 sequestration into peripheral non-lysosomal 
compartments, an evolutionary optimized viral strategy for avoiding lysosomal 
degradation, forms the basis for novel AVN-based delivery strategies that can minimize 
the intracellular degradation of sensitive cargo. Due to their ability to target key cells of 
the immune system and to initiate non-lysosomal uptake routes, GM3-functionalized 
AVNs can contribute significantly to overcome key challenges in drug delivery. 
 
4.4 Recaptulating virological synapse formation with GM3-AVNs 
4.4.1 Formation of AVN clusters upon binding with mDCs 
Utilizing AVNs' unique multi modal properties, we were able to further characterized the 
formation process of AVN clusters on mDCs. 
Tracking of AVN particles and analysis of the movements of particles will provide 
insights of the driving force and mechanism of the cluster formation (Burckhardt, 
Suomalainen et al. 2011). 
Here we only applied AVN2 as sketched in session 4.1 Figure 4.1 and generally call it 
here AVN. The reason to use AVN2 in this case is due to the simplicity of fabrication 
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process, as well as similarity of AVN2 with HIV-1 viruses since it contains individual 
AuNPs inside the membrane shell. 
With the large scattering cross-section of nano gold particle core of AVNs, we were able 
to track the particle for prolonged time with stable signal intensity with dark-field 
microscopy. To make sure the cells are alive, we built an incubator around the 
microscope, as illustrated in Figure 4.16. 
 
Figure 4.16. Microscope and incubator setup for live tracking of AVN cluster formation 
 
With the above setup, 1x108 GM3-containing AVNs were mixed with 3x105 DCs at 4˚C 
for 10min, and centrifuge away the free unbound AVNs. The DCs were then placed into 
round dishes with poly-lysine treated glass bottom. CO2-independent medium (Life 
Technology) were added after the cells sedimented on the bottom, to ensure the liquid 
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environment for the live cells. The cells were taken to the microscope equipped with an 
incubator and warmed up to 37˚C. The AVN movement on DCs was recorded by 
EMCCD from the beginning of the warming up process. 
We recorded more than 50 trajectories for 3 mDCs that showed AVN clustering 
distributions, in 3 independent experiments, at different cluster formation stages. The 
recorded movies were further analyzed by MATLAB to extract exact positions of each 
particle. Gaussian fitting was done to each chosen particle, to give a precise read out for 
the particle position in each frame of each trajectory movie.  
Figure 4.17 shows 2 snapshots of one mDCs at selected time points, together with 20- 
second trajectories of 6 selected AVNs pointed out in the images. It could be seen that the 
particles pointed out in Figure 4.17 a left panel eventually migrated into a confined area 
pointed out in Figure 4.17 a right panel.  
The selected AVNs trajectories are shown in Figure 4.17b, with gray arrowheads pointing 
out the starting point of each trajectory. 20s movies were recorded, 1 second per frame 
for each trajectory. We observed a broad distribution of types of particle movements. 
Trajectory 1 features with long directed motion with a little dwelling in the middle of the 
path. Trajectory 3,4,6 are confined motion with limited diffusion within certain range, 
and we attribute these to AVNs immobilized on cell surfaces. Trajectory 2,5 are typical 
motions of particles that a certain period of directed motion pattern is observed, after 
which some diffusion dominate the movement pattern.  
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Figure 4.17 Live tracking of AVN cluster formation. 
a. 2 Snapshots of one mDC containing AVNs at selected time points. The AVNs redistributed 
into one confined area after around 8 minutes. 
b. Trajectories of 6 selected AVNs pointed in a). The arrow head points out the starting points. 
 
To develop an idea of the diffusion patterns of the particles, we calculated Moment 
Scaling Spectrum Slope (MSS-Slope) for the 53 trajectories that we collected.  
Ferrari et al. (Ferrari 2001) elaborates the moment scaling spectrum and Rong et al. 
(Rong, Wang et al. 2010) applied the calculation of MSS-Slopes for silver particles' 
translational diffusion patterns. 
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 In brief, a moment µ of order υ for a specific frame shift Δn corresponds to a time shift δt 
=ΔnΔt where Δt is the fixed time interval between two frames, could be expressed as: 
 
Here x⃗  l (n) is the position vector (xl(n),yl(n)) on trajectory l at t =nΔt. The scaling 
coefficients γν can be obtained by linearly fitting the power law µν(δt) ∝ δtγν to double 
logarithmic plots of µν vs. δt, and the 2 dimensional diffusion coefficients Dν of ν > 0 can 
be obtained from ordinate intercept It via Dv = (2v)−1 exp(It). When ν = 2, the coefficient 
is the linear diffusion coefficient. And the plot of γν vs. ν is the moment scaling spectrum. 
The slope of the plot is called moment scaling spectrum slopt (MSS Slope), and indicates 
the mobility of the tracked particle. For free diffusion, MSS Slope is 0.5, and for 
completely immobilized or directed motion, the MSS Slopes are 0 and 1 respectively. 
(Sbalzarini and Koumoutsakos 2005) 
Figure 4.18 shows the MSS-Slope vs. D2 for all the 53 trajectories. We observed a broad 
distribution of particles motions, as for some low diffusion coefficient particles, they 
show large MSS-Slopes indicating the motion is directed, while for some large D2 
particles, they show more random or confined movements.  
85	  	  
	  
 
Figure 4.18 MSS Slope vs. D2 plot. 
We further characterized the maximum speeds of each trajectory, as shown in Figure 4.19. 	  
 
Figure 4.19 Histogram of maximum speeds of ~50 trajectories.  
Most particles have a maximum speed below 2um/s. 	  
For MSS Slopes below 0.5, we deem as confined motion, while for MSS Slope above 0.5, 
we deem as directed motion. And we analyzed the averaged speed of each category, as 
shown in Figure 4.20. 
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It can be seen that, for MSS Slope larger or smaller than 0.5, the distribution of the 
average speeds are similar to each other, which means there's no significant speed change 
resulted from the motion pattern.  
 
Figure 4.20 Histogram of averaged speed for particles with MSS Slope <0.5 and MSS 
Slope >0.5. 
 
Combining the above observations, we concluded that, the AVNs can migrate towards 
the clustering center with low speeds, but the motion is very directed to the clustering 
center. Although the diffusion could be rather constrained, the net movement results in 
the directed motion to form clusters.  
To obtained a general idea about the re-distribution from a more random pattern to 
clustered pattern, we further characterized statistically large quantity of mDCs challenged 
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with GM3-AVNs, at various time points. 
In detail, 1x108 GM3-containing AVNs were added to 3x105 DCs, and incubated in 
serum free RPMI-1640 at 37˚C for 5min, 10min, 20min, 30min, 45min and 60min. Free 
unbound AVNs were then removed by centrifugation twice, and fixed by 4% 
paraformaldehyde. The cells were then cytospun onto glass coverslips (24 mm x 60 mm) 
and inspected under dark-field microscope. Counts of DCs with AVN clusters, as well as 
counts of DCs with AVN random patterns, were collected from recorded movies across 
the entire imaging area, to ensure the randomness and fairness for the sample set. 
The result is shown in Figure 4.21. 
 
Figure 4.21 Distribution of AVNs upon binding with mDCs. 
a. Distribution patterns of AVNs upon binding with mDCs. Scale bar = 1um 
b. Relative occurrence of 'Cluster' and 'Random' patterns and total occurrence of DCs with AVNs. 
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It can be seen from Figure 4.21 a that the distribution of AVNs can be divided to 3 
patterns, 'No AVN' when no AVN binds with mDCs, 'Cluster' when AVNs form clusters, 
or 'Random', when AVNs don't form cluster but distributed randomly. Figure 4.21 b plots 
the details of the relative occurrence of these patterns. The 'Cluster' pattern increases 
while the 'Random' pattern decreases fast within the initial 10min, and continue their 
trends in the following 50min gradually. Note that the total occurrence of DCs with 
AVNs, i.e. 'Cluster' + 'Random' patterns' occurrence is almost constant after 30min, at 
around 50% of the total population, indicating the increase of 'Cluster' and decrease of 
'Random' are internal transitions from one to the other. This observation is consistent 
with our live tracking result, showing the migration of particles forms random 
distribution to a certain cluster center and results in the 'Cluster' formation. 
4.4.2 Virological synapse formation triggered by AVNs 
An immunological synapse defines an organized tight contact between an antigen 
presenting cell and a lymphocyte that plays an important role in ensuring an efficient 
communication between key components of the immune system. A series of diseases 
ranging from cancer to autoimmune disorders would benefit from a selective targeting of 
the immunological synapse with therapeutic NPs and delivery systems. Interestingly, 
lymphotropic retroviruses, such as the human immunodeficiency virus type 1 (HIV-1), 
have evolved to hijack cellular trafficking and signaling mechanisms to achieve an 
accumulation at the cell-to-cell contact and to reprogram the synapse formation into a 
virological or infectious synapse. The latter facilitates an efficient replication-
independent transmission of the HIV-1 virus to CD4+ T-cells, which are the preferred 
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host cells of the virus. In the case of HIV-1, engagement of the sialoadhesin CD169 by 
the α2-3 linked ganglioside GM3 contained in the viral membrane is sufficient to trigger 
a localization of virus particles to the cellular periphery and, upon initiation of a mDC-T 
cell contact, a trafficking to the mDC-T cell infectious synapse.(Izquierdo-Useros, 
Lorizate et al. 2012, Puryear, Akiyama et al. 2012) The GM3-CD169 mediated cellular 
uptake and trafficking mechanisms provide, therefore, unique opportunities for a site 
selective delivery with appropriately designed NP platforms. Potential advantages of this 
strategy include the targeting of a specific cell population (CD169 expressing 
macrophages and dendritic cells), uptake via a non-lysosomal pathway, and the ability to 
modulate mDC-T cell signaling by selectively delivering therapeutic NPs to the 
virological synapse.  
Here we were able to show that GM3-AVNs are sufficient to achieve their preferential 
localization at the mDC-T cell interface. Our experimental strategy takes advantage of 
the superb photophysical properties of the gold NP core to monitor the intracellular fate 
of AVNs at the single NP level. In particular, we probe the cellular mechanisms that 
result in the enrichment of AVNs at mDC-T cell contacts, which share strong molecular 
resemblances with virological synapses. 
Experimentally, 1x108 GM3-containing AVNs were added to 3x105 DCs and incubated at 
37˚C for 1.5h in serum free RPMI-1640, and centrifuged at 270 xg to purify from free 
unbound AVNs. The DCs were then mixed with CD4+ T cells in 1:1 ratio and incubated 
in serum free RPMI-1640 at 37˚C for 5min, 15min, 30min, 45min, 60min, 120min, and 
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240min respectively, fixed with 4% paraformaldehyde, and cytospun onto glass 
coverslips for further imaging and counting. 
 
Figure 4.22 Distribution patterns of AVNs upon DC-T conjugates formation. 
a. Five possible distribution patterns of AVNs on DC-T conjugates. Scale bars = 1µm. 
b. Statistical analysis of occurrences of different patterns. 
 
Figure 4.22 a shows the five possible distribution patterns for DCs containing GM3 
AVNs upon binding with T cells. We categorize the DC-T conjugates by drawing lines 
dividing the DCs to hemisphere contacting or not contacting the T cells. For conjugates 
with no AVN or random AVN bindings, we name them as 'No AVN and 'Random' 
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respectively. For AVNs locate at the T cell hemisphere, we call it 'Oriented', while if 
AVNs locate at the DC cell without T cell hemisphere, we call it 'Non-Oriented'. 
Additionally, 'Transferred to T cell' indicates the pattern that contains AVNs on T cells. 
We only consider conjugates with less than 2 T cells per DCs in this study. The dividing 
method for 2 T cell conjugates is shown in Figure 4.23. 
 
Figure 4.23 Dividing method for 2 T cell conjugates.  
Scale bar = 1µm. 	  
The results of this classification for a total of approximately 200 mDCs from 2-3 different 
donors for each time point are summarized in Figure 4.22 b (i) and (ii). The Oriented 
pattern shows a continuous increase within the first 60min, while the Non-Oriented 
pattern decreases (Figure 4.22 b (i)). The ratio changes from 1:1 to 3:2.  This ratio 
remains approximately constant if the incubation time is further increased. The total 
occurrence of DCs with AVN clusters (i.e. total of Oriented and Non-Oriented patterns) 
increases to approximately 71% quickly within the initial 15min and remains almost 
constant for longer time incubation (Figure 4.22 b (ii)). 
The anti-correlated changes in the occurrence of Oriented and Non-Oriented within the 
first 60 min of observation indicates a relative motion of AVN clusters and T cells 
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towards each other. To test this hypothesis, we continuously imaged mDC-T cell 
conjugates as function of time and monitored the alignment of AVN cluster and T cell. 
mDCs pulsed with GM3-AVNs at an AVN/mDC ratio of 1x108/3x105 for 1.5h at 37˚C in 
serum free growth medium were immobilized onto poly-lysine treated glass bottom 
dishes. mDCs that contain AVN clusters were located in the dark-field microscope 
equipped with a cage incubator and centered in the field of view. CD4+ T cells pre-
stained with CellTracker Orange were subsequently added using a customized micro-
manipulator equipped with a pipette that made it possible to dispense a T cell containing 
solution at defined locations. The T cells bound efficiently to the mDCs upon contact 
formation, and a binding event defined the starting point for the optical tracking. Our 
optical set-up allowed the acquisition of both fluorescence and elastic scattering images, 
ensuring a precise localization of both fluorescently marked T cell and AVN cluster. 
The live cell imaging studies revealed two different relative motion patterns between 
AVN clusters and T cells. The most commonly observed motion is illustrated in Figure 
4.24 a. This figure displays a series of mDC-T cell images at different time points 
constructed by superimposing the fluorescence image of the T cell onto the dark-field 
scattering image of the mDC-T cell conjugate. The images show a fairly rapid motion 
(‘rolling’) of the lT cell across the mDC surface within the first ten minutes that leads the 
T cell into the vicinity of the AVN cluster (green arrow). The T cell motion stops almost 
entirely once the cell has reached the vicinity of the AVN cluster. The dislocation of the 
T cell converts the AVN pattern in the mDC-T cell conjugate from the Non-Oriented into 
the Oriented form in the course of approximately 10min. We continued to image the 
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mDC-T cell conjugate for another 20min and did not observe any further movement of 
the T cell.  
We observed similar T cell rolling behaviors that eventually resulted in an 
immobilization of the T cell in the vicinity of an AVN cluster for more than five different 
mDC-T cell conjugates in three independent experiments. The observed mobility of the T 
cells is consistent with previous studies that have shown that T cells translate over DC 
surfaces upon initial contact to “scan” surface features and identify potential binding sites. 
Our T cell tracking data indicate that AVN segregation in mDCs induces the presentation 
of such surface features that result in the trapping of scanning T cells in close vicinity of 
the peripheral AVN cluster. 
Figure 4.24b illustrates a second pattern of relative mDC-T cell motility. Here, the T cells 
in contact with the mDC do not systematically scan over the cell surface but, instead, 
remain located close to their original binding sites. Interestingly, in this case of 
immobilized T cells, the AVN cluster (green arrow) migrates towards one of the bound T 
cells and reaches the mDC-T cell contact area within 30min. The observed average speed 
for the AVN cluster displacement is at the level of 100 nm /min, which is much slower  
than observed for the individual GM3-AVNs involved in its formation. Although it is 
known that the DC cytoskeleton can be restructured upon formation of a DC-T cell 
conjugate, these changes are usually assumed to be localized to the cell-cell contact area. 
Our imaging experiments indicate that cytoskeletal changes are possible even in cell 
regions remote from the actual cell-to-cell contact to propel the AVN cluster towards the 
T cell. The direct motion of the AVN cluster was, however, much less frequent than the T 
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cell scanning of Figure 4.24 a and we cannot exclude that the immobilization of the T 
cells was a consequence of their binding to the glass bottom of the dish. Future tracking 
studies in free-floating mDC-T cell conjugates will be able to determine the relevance of 
this second motion pattern. 
 
Figure 4.24 Tracking of virological synapse formation. 
a. Rolling of T cell over DC surface mechanism. 
b. Migrating of AVN cluster over DC surface mechanism. 	  
Our optical imaging and tracking studies show clearly that T cells bind preferentially at 
the locations of GM3-AVN clusters, but they provide no insight into the nature of the 
mDC-T cell at the contact point. We consequently performed immunofluorescence 
studies in which we checked for colocalization between AVNs clusters and markers of 
virological synapses t the mDC-T cell contact (Figure 4.25). The compartment containing 
the GM3-AVN cluster is firstly enriched with CD169, indicative of an intact GM3-
CD169 association (Figure 4.25a). This observation indicates that the GM3 containing 
membrane is stable on the timescale of our experiments. It also confirms the successful 
mimicry of viral trafficking patterns through GM3-AVNs as CD169 was observed before 
to colocalize with VLPs at the virological synapse. Figure 6b further shows the 
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tetraspanin CD81 colocalize with the GM3-AVN cluster in mDC-T cell conjugates with 
an Oriented GM3-AVN distribution, which also indicates of the virological synapse 
formation. We also stained actin network with fluorescein phalloidin, and observed an 
enrichment of phalloidin at AVN clustered area, confirming an enhanced activity of 
cellular actin network towards the virological synapse. 
 
Figure 4.25 Staining of DC-T conjugates to confirm virological synapse formation. 
a. Staining of CD169 colocalized with AVN cluster. 
b. Staining of CD81 colocalized with AVN cluster. 
c. Staining of actin network colocalized with AVN cluster. Scale bars = 1µm. 
 
4.4.3 Discussion 
Our imaging studies reveal that GM3-AVNs subvert GM3-CD169 mediated uptake and 
trafficking to achieve a preferential localization of AVNs at mDC-T cell contacts that 
resemble virological synapses. Under our experimental conditions, in which mDCs were 
pre-incubated with GM3-AVNs before T cells were added, we observed in the majority 
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of cases that the local enrichment of AVNs at the cell-to-cell contact was the result of a 
binding of surface-scanning CD4+ T cells in the vicinity of non-lysosomal peripheral 
GM3-AVN clusters, which formed rapidly within 10-30 min after AVN exposure. A 
trafficking of the GM3-AVN clusters towards T cells was observed only in a few cases 
and does not seem to be the dominating formation pathway. A characterization of the 
formed contacts through immunofluorescence confirms the presence of virological 
synapse markers, such as CD81 and CD169.  
While the enrichment of AVNs at the virological synapse between mDC and T cell is 
common, the transfer of AVNs from mDC to T cell is rare (less than 1% of the total AVN 
containing mDC-T conjugates, Figure 4.26) even after prolonged co-culturing of mDCs 
and T cells. This finding indicates that additional factors besides GM3 are required to 
achieve an efficient transfer of AVNs to T cells. Despite these limitations with regard to 
an AVN transfer from mDC to T cell, the demonstrated ability to induce the formation of 
a virological synapse like cell-to-cell contact proves the capacity of GM3-AVNs to target 
key events in the adaptive immune system, which has tangible translational potential for 
enhanced immunization and therapeutic strategies. 
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Figure 4.26 Occurrences of 'No AVN', 'Random' and 'Transferred to T cell' patterns. 
Our studies also have important fundamental implications. The mimicry of viral synapse 
formation with a minimalistic GM3-AVN virus model void of any virus or host encoded 
glycoproteins suggests that GM3-CD169 interaction are not only responsible for 
achieving an efficient uptake and binding of viral particles, but that they also play a role 
in establishing the viral synapse. 
4.5 Conclusions 
AVNs have shown high similarity with virus behaviors in HIV-1 lipid dependent trans-
infection model. Both lipid bilayer and lipid monolayer resulted in successful particle 
capture by CD169 presenting cells, and triggered the downstream virus-like behavior till 
virological synapses. With AVN model, we confirm the specific interaction of GM3 with 
CD169 that initiate the capture of particles. We further show that the GM3 presence 
without any envelope membrane glycoprotein could trigger the AVN redistribution 
across CD169 containing cell surfaces. Furthermore, upon DC-T conjugates formation, 
virological synapse-like structure forms with AVN cluster locates at the DC-T contact 
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area that's enriched with CD81 and phalloidin. We observe the T rolling across the DC 
surface as well as AVN migration that result in the virological synapse structure 
formation. One thing to note is that AVNs barely transfer to T cells, which indicates more 
factors other than GM3 should be needed to trigger further particle transmission.  
The simplified AVN model opens a window for selective investigation of individual 
parameters, such as GM3-CD169 interaction in this case, in a non-complicated way with 
straightforward imaging setup. The combination of optical microscopy with the 
traditional electron microscopy enables the detection of particles with high resolutions 
and fast output.  
This work designed and tested 3 smart nanoparticles - liposomes, AuNPs, and AVNs for 
bio-imaging applications. We need to note the simplicity of the AVN model, which 
combines the advantages of liposome probes and the AuNP cores, which provided 
membrane surfaces that's similar to viral membranes and enabled tracking of particles 
with the multimodality of the optical core, and overcame the disadvantages of softness of 
liposomes and nature discrepancy of AuNPs without membrane shells. The development 
of AVN system paves the way to understand details of virus infections and biological 
processes for opportunities of virus infection control and virus disease therapies. 	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APPENDIX 
i Matlab code for individual gold cluster spectra analysis 
startdair = ''; 
datadir_default = ''; 
processing_file = ''; 
code_dir = ''; 
datadir = uigetdir(datadir_default) 
cd(datadir) 
promptstring = strcat('Open Data File') 
[filename,path] = uigetfile('*.mat',promptstring) 
temp_data = load(filename) 
movie = temp_data.movie(:,:,1); 
movie = movie'; 
% show the image 
figure(1) 
hold on 
imagesc(movie) 
colormap(gray) 
title ('original figure') 
select background 
pause 
choicewin = menu('Do you want to choose the background?', 'Yes','No') 
100	  	  
	  
if choicewin ==1  
 [x0,y0,z0]=impixel; 
end 
S0 = sum(movie((y0-1:y0+1),:,1),1); 
% select sample area  
n = input('How many particles do you want to analyze in the picture'); 
%WL normalization 
wl(:,1)= WL(:,2); 
wlafternorma(:,1)=wl(:,1)/max(wl(:,1)); 
wlfactor = wlafternorma'; 
wv(1,:)= WL(:,1); 
%wl and bg correction 
j=1 
for i = 1:99 
    figure(i+1) 
    S = sum(movie((j:(j+1)),:,1),1); 
    S_bg(i,:)=S-S0*2; 
    S_bgwl(i,:) = S_bg(i,:)./wlfactor; 
    normS(i,:) = S_bgwl(i,:)./max(S_bgwl(i,:)); 
    windowsize = 40; %this determines how many points you average 
    slidav(i,:) = filter(ones(1,windowsize)/windowsize,1,normS(i,:));    
    norm_slidav(i,:) = slidav(i,:)./max(slidav(i,:)); 
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    plot(wv(1,:),norm_slidav(i,:)); 
    [r,c,v]=find(norm_slidav(i,:)==1); 
    wavelength(2,i) = wv(1,c); 
    wavelength(1,i) = i; 
    j=j+2; 
    figure(1) 
end 
cd('') 
ii Matlab code for SEM particle density calculation 
close all 
clear all 
startdir = ''; 
code_dir = ''; 
datadir_default = ''; 
datadir = uigetdir(datadir_default) 
cd(datadir) 
promptstring=strcat('Open Data file') 
[filename,path] = uigetfile('*.jpg',promptstring) 
imdata= imread(filename); 
cd(code_dir) 
figure 
imagesc(imdata(:,:,1)) 
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colormap(gray) 
imag = imdata(1:692,:,1); 
figure 
imagesc(imag(:,:,1)) 
colormap(gray) 
hold on 
img_filt = bpass(imag(:,:,1),1,5); 
pk = pkfnd(img_filt,30,3); 
points = size(pk,1); 
for k = 1:points 
    corri(k,1) = k; 
    corri(k,2) = pk(k,1); 
    corri(k,3) = pk(k,2); 
    plot(pk(k,1),pk(k,2),'ro') 
end  
hold off 
X1 = input('what is the left end coordinate of scale bar? '); 
X2 = input('what is the right-end coordinate of scale bar? '); 
scale = input('what is the representive length of scale bar'); 
pixel_size = scale/(X2-X1); 
imag_size = 1024*692/((X2-X1)^2)*(scale^2); 
density = points/imag_size 
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cd('') 
iii Matlab code for RGB histogram plot 
%File--> Open--> select your jpg digital image (original one, not scaled) a window will 
pop out. click finish. 
%Then you see the file in the workspace as a 3-d matrix. Change its name to S (Case 
sensitive) 
%Run RGB_hist 
imagesc(S) 
[y1,x1,z1]=impixel; 
[y2,x2,z2]=impixel; 
% Wait for the image to show, your cursor becomes cross. So choose a small area by 
double click the top left corner, then double  clicking the bottom right corner. You're 
analysing the selected  rectangular area. 
R1=S(x1:x2,y1:y2,1); 
G1=S(x1:x2,y1:y2,2); 
B1=S(x1:x2,y1:y2,3); 
figure(2) 
imagesc(S(x1:x2,y1:y2)) 
% After you selected the area, the heat map of the selected region will pop out as an 
image. So that you know where you selected. 
R1=double(R1); 
G1=double(G1); 
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B1=double(B1); 
norm_R1 =R1./(R1+G1+B1); 
norm_G1= G1./(R1+G1+B1); 
norm_B1 = B1./(R1+G1+B1); 
RGB(:,1)=reshape(norm_R1.', 1, [])'; 
RGB(:,2)=reshape(norm_G1.', 1, [])'; 
RGB(:,3)=reshape(norm_B1.', 1, [])'; 
%Now you will have a matrix called RGB. The first column is contribution from red 
channel by every pixel in the area; 2nd column, green; 3rd, blue.  
iv Matlab code for plotting particle trajectory (tracking & Gaussian fitting) 
first_frame = input ('What is the starting frame number of the video?'); 
last_frame = input ('What is the ending frame number of the video?'); 
increment = 1; 
particle_number = input ('How many particles for the video?'); 
time_resol=input('what is the time interval between each frame');       
frame_size=512; 
range=1;gaussian_range=4;pixel_size=0.1428; 
for particle_num = 1:particle_number 
    imagesc(movie(:,:,first_frame)); 
    hold on 
    title(sprintf('Please Select the Particle to Track')); 
    pause 
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    [x1,y1,z1] = impixel; 
    close 
    xpeak=x1; ypeak=y1; 
    traj_len=last_frame-first_frame+1; 
    trajectory=zeros(traj_len,11); 
    for i=1:traj_len 
        movie_subset1=movie(ypeak-range:ypeak+range,... 
            xpeak-range:xpeak+range,first_frame+i-1); 
        [~,x_max]=max(max(movie_subset1,[],1)); 
        [~,y_max]=max(max(movie_subset1,[],2)); 
        xpeak=x_max+xpeak-range-1; 
        ypeak=y_max+ypeak-range-1; 
        trajectory(i,1)=xpeak; 
        trajectory(i,2)=ypeak; 
        trajectory(i,3)=first_frame+i-1; 
        movie_subset2=movie(ypeak-gaussian_range:ypeak+gaussian_range,... 
            xpeak-gaussian_range:xpeak+gaussian_range,trajectory(i,3)); 
        x=(xpeak-gaussian_range:xpeak+gaussian_range); 
        y=(ypeak-gaussian_range:ypeak+gaussian_range); 
        movie_subset2=double(movie_subset2); 
        [fitresult,gof]=GFit_plus_bg_nofig(x,y,movie_subset2,... 
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            xpeak-gaussian_range+1,xpeak,xpeak+gaussian_range-1,ypeak-
gaussian_range+1,ypeak,ypeak+gaussian_range-1); 
        coeffval=coeffvalues(fitresult); 
        trajectory(i,6)=coeffval(1);  
        trajectory(i,7)=coeffval(2); 
        trajectory(i,8)=coeffval(3);  
        trajectory(i,9)=coeffval(4);  
        trajectory(i,4)=coeffval(5);  
        trajectory(i,5)=coeffval(6);  
        trajectory(i,10)=2*coeffval(1)*pi*coeffval(3)*coeffval(4);           
trajectory(i,11)=gof.rsquare; 
        xpeak=round(trajectory(i,4)); 
        ypeak=round(trajectory(i,5)); 
    end 
scale=[3000 9000]; 
traj_cell{1}=trajectory; 
nframes=size(movie,3); 
num_particle=size(traj_cell,2); 
M=moviein(nframes); 
traj_info=zeros(num_particle,3); 
for p=1:num_particle 
    if ~isempty(traj_cell{p}) 
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    traj_info(p,1)=traj_cell{p}(1,3); 
    traj_info(p,2)=traj_cell{p}(end,3); 
    traj_info(p,3)=randi([1 7]); 
    end 
end 
ColList='ymcrgbw'; 
for frame=1:nframes 
    colormap('gray'); 
    hold on 
    axis([190 290 250 350]); 
    caxis(scale); 
    for p=1:num_particle 
        if frame>=traj_info(p,1) && frame<=traj_info(p,2) 
            plot(traj_cell{p}(1:frame-traj_info(p,1)+1,4),... 
                traj_cell{p}(1:frame-traj_info(p,1)+1,5),... 
                ColList(traj_info(p,3)),'LineWidth',1); 
        end 
    end 
    hold off 
    drawnow 
    pause(1) 
    M(:,frame)=getframe; 
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end 
end 
v Matlab code for Moment Scaling Spectrum Slope calculation 
numfiles = 1; %or change file numbers 
for i = 1:numfiles 
    x.dimer(:,i)=trajectory(:,4); 
    y.dimer(:,i)=trajectory(:,5); 
end 
 pixel_size = input('what is the pixel size?(unit: micro m)'); 
 Delta_t = input('what is the temporal resolution for this set of movies(unit:s)?'); 
for l=1:numfiles 
 temp_Log_miu = 0; 
 temp_size= (size(x.dimer(:,l))); 
 M=temp_size(1,1); 
   for nu = 0:6 
     for Delta_n = 1:round(M(l)/2) 
         temp_miu = 0; 
         for n = 1:(M-Delta_n-1) 
             temp_miu = temp_miu + (((x.dimer((n+Delta_n),l) x.dimer((n),l))^2 + 
(y.dimer((n+Delta_n),l)-y.dimer((n),l))^2)^(nu/2))/(M(l)-Delta_n); 
         end  
         miu(l,(nu+1),Delta_n)=temp_miu;                                 
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         delta_t(1,Delta_n) = Delta_n * Delta_t; 
         Log_miu(l,(nu+1),Delta_n)=log(miu(l,(nu+1),Delta_n)); 
         temp_Log_miu(nu+1,Delta_n)= Log_miu(l,(nu+1),Delta_n); 
         Log_delta_t(1,Delta_n)=log(delta_t(1,Delta_n)); 
     end 
     temp_para=polyfit(Log_delta_t(1,:),temp_Log_miu((nu+1),:),1); 
     gamma(l,(nu+1))= temp_para(1,1); 
     if nu==2 
     D2(l)=exp(temp_para(1,2))/4*(pixel_size^2); 
   end 
end 
    temp_MSS = polyfit((0:6),gamma(l,:),1); 
    MSS_slope(l)=temp_MSS(1,1); 
    sum_MSS_slope(l, 1) = temp_MSS(1,1); 
    sum_D2(l,1)= D2(l); 
end 
vi Matlab code for particle speed calculation 
time_interval = input ('what is the time interval between each frame?') 
for framenumber = 2:length(trajectory) 
    d(framenumber)=((trajectory(framenumber-1,4)-
trajectory(framenumber,4))^2+(trajectory(framenumber-1,5)-
trajectory(framenumber,5))^2)^(1/2)*0.1428; 
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    speed_time_plot(framenumber,2)=d(framenumber)/time_interval; 
    speed_time_plot(framenumber,1)=(framenumber-1)*time_interval; 
end 
sliding_factor = input('what is the sliding factor'); 
for framenumber=2:(length(trajectory)-sliding_factor) 
    vect_d(framenumber-1+sliding_factor)=((trajectory(framenumber-1,4)-
trajectory(framenumber+sliding_factor-1,4))^2+(trajectory(framenumber-1,5)-
trajectory(framenumber-1+sliding_factor,5))^2)^(1/2)*0.1428; 
    vect_sliding_speed_time_plot(framenumber-1+sliding_factor,2) = 
vect_d(framenumber-1+sliding_factor)/(time_interval*sliding_factor); 
    vect_sliding_speed_time_plot(framenumber-1+sliding_factor,1)=(framenumber-
1+sliding_factor)*time_interval; 
end 
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